Document:

-- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Exhibit 4.4 

 

 

 

WARRANT AGREEMENT 

  

  by and between 

  

  TRIAN ACQUISITION I CORP. 

  

  and 

  

  AMERICAN STOCK TRANSFER & TRUST COMPANY 

  

 Dated as of November 1, 2007 

 

 

 

 

 

TABLE OF CONTENTS 

	 

		 
		 

		 
		
Page
	
	 

	
	
ARTICLE I APPOINTMENT OF WARRANT AGENT
		 
		
2
	
	 

	
	
ARTICLE II
		 
		
WARRANTS
		 
		
2
	
	
2.1
		 
		
Form of Warrant
		 
		
2
	
	
2.2
		 
		
Effect of Countersignature
		 
		
2
	
	
2.3
		 
		
Registration
		 
		
2
	
	
2.4
		 
		
Detachability of Warrants
		 
		
3
	
	
2.5
		 
		
Private Warrants
		 
		
4
	
	 

	
	
ARTICLE III
		 
		
TERMS AND EXERCISE OF WARRANTS
		 
		
5
	
	
3.1
		 
		
Warrant Price
		 
		
5
	
	
3.2
		 
		
Duration of Warrants
		 
		
5
	
	
3.3
		 
		
Exercise of Warrants
		 
		
6
	
	
3.4
		 
		
No Cash Settlement
		 
		
9
	
	 

	
	
ARTICLE IV
		 
		
ADJUSTMENTS
		 
		
9
	
	
4.1
		 
		
Stock Dividends; Split-Ups
		 
		
9
	
	
4.2
		 
		
Aggregation of Shares
		 
		
9
	
	
4.3
		 
		
Adjustments in Warrant Price
		 
		
9
	
	
4.4
		 
		
Replacement of Securities upon Reorganization, etc
		 
		
9
	
	
4.5
		 
		
Extraordinary Dividends
		 
		
10
	
	
4.6
		 
		
Notices of Changes in Warrant
		 
		
10
	
	
4.7
		 
		
No Fractional Shares
		 
		
11
	
	
4.8
		 
		
Form of Warrant
		 
		
11
	
	
4.9
		 
		
Notice of Certain Transactions
		 
		
11
	
	 

	
	
ARTICLE V
		 
		
TRANSFER AND EXCHANGE OF WARRANTS
		 
		
12
	
	
5.1
		 
		
Transfer of Warrants
		 
		
12
	
	
5.2
		 
		
Registration of Transfer
		 
		
12
	
	
5.3
		 
		
Procedure for Surrender of Warrants
		 
		
12
	
	
5.4
		 
		
Fractional Warrants
		 
		
12
	
	
5.5
		 
		
Service Charges
		 
		
12
	
	
5.6
		 
		
Warrant Execution and Countersignature
		 
		
12
	
	 

	
	
ARTICLE VI
		 
		
REDEMPTION
		 
		
13
	
	
6.1
		 
		
Redemption
		 
		
13
	
	
6.2
		 
		
Date Fixed for, and Notice of, Redemption
		 
		
13
	
	
6.3
		 
		
Exercise After Notice of Redemption
		 
		
14
	
	
6.4
		 
		
Outstanding Warrants Only
		 
		
14
	
	 

	
	
ARTICLE VII
		 
		
OTHER PROVISIONS RELATING TO RIGHTS OF HOLDERS
		 
		 

	
	 

		 
		
OF WARRANTS
		 
		
14
	
	
7.1
		 
		
No Rights as Stockholder
		 
		
14
	
	
7.2
		 
		
Lost, Stolen, Mutilated, or Destroyed Warrants
		 
		
14
	

(i) 

TABLE OF CONTENTS 

(Continued) 

						Page
	
	7.3			Reservation of Common Stock		14
	7.4			Registration of Common Stock		15
	
	 			 		
	ARTICLE VIII			CONCERNING THE WARRANT AGENT
        AND OTHER		
				MATTERS		15
	8.1			Payment of Taxes		15
	8.2			Resignation, Consolidation,
        or Merger of Warrant Agent		15
	8.3			Fees and Expenses of Warrant
        Agent		16
	8.4			Liability of Warrant Agent		16
	8.5			Acceptance of Agency		17
	8.6			Waiver		17
	
	 			 		 
	ARTICLE IX			MISCELLANEOUS PROVISIONS		18
	9.1			Successors		18
	9.2			Notices		18
	9.3			Applicable Law		18
	9.4			Persons Having Rights under
        this Agreement		19
	9.5			Examination of the Warrant
        Agreement		19
	9.6			Counterparts		19
	9.7			Effect of Headings		19
	9.8			Amendments		19
	9.9			Severability		19
	9.10 		Entire Agreement		20

(ii) 

WARRANT AGREEMENT 

          This WARRANT AGREEMENT (this “Agreement”) is made as of November 1, 2007, by and between Trian Acquisition I
Corp., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agent”). 

          WHEREAS, in connection with its formation, the Company has issued and sold to Trian Acquisition I, LLC, a Delaware limited liability company (the “Sponsor”), an aggregate of 21,562,500 units (the “Sponsor Units”), each consisting of one share of common
stock, par value $0.0001 per share, of the Company (“Common Stock”) and one warrant entitling
the holder thereof to purchase one share of Common Stock for $7.50, subject to adjustment as described herein (such warrants, the “Initial Sponsor Warrants”);

          WHEREAS, the Company is proposing to file a registration statement (the “Registration Statement”) on Form S-1
under the Securities Act of 1933, as amended (the “Securities Act”) with the Securities and Exchange Commission in connection with an initial public offering (the
“Initial Public Offering”) of 75,000,000 units (or up to 86,250,000 units if and to the extent that the underwriters exercise their over-allotment option) (the
“Public Units”), each consisting of one share of Common Stock and one warrant entitling the holder thereof to purchase one share of Common Stock for $7.50, subject to
adjustment as described herein (such warrants, the “Public Warrants”); 

          WHEREAS, the Sponsor has agreed to purchase from the Company an aggregate of 10,000,000 additional warrants at a price of $1.00 per warrant in a private placement that will occur immediately
prior to the Initial Public Offering, each such Warrant entitling the holder thereof to purchase one share of Common Stock for $7.50, subject to adjustment as described herein (such warrants, the “Sponsor
Warrants,” and together with the Initial Sponsor Warrants, the “Private Warrants”); 

          WHEREAS, the Public Warrants and the Private Warrants are sometimes collectively referred to herein as the “Warrants;”

          WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange,
redemption, exercise and cancellation of the Warrants; 

          WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights,
and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and 

          WHEREAS, all acts and things have been done and performed that are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent,
as provided herein, the valid, 

binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement; 

          NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows: 

ARTICLE I 

APPOINTMENT OF WARRANT AGENT 

          The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the same in
accordance with the terms and conditions set forth in this Agreement. 

ARTICLE II 

WARRANTS 

          2.1     Form of Warrant. Each Public Warrant shall be issued in registered form only
in substantially the form of Exhibit A hereto and each Private Warrant shall be issued in registered form only in substantially the form of Exhibit B hereto, the provisions of which exhibits are incorporated herein. Each Warrant shall be signed by, or bear the facsimile signature of, any one of the Chairman of the Board of Directors, the
Vice Chairman, President, Chief Financial Officer, Treasurer, Chief Legal Officer, Secretary or Assistant Secretary of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the
capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same effect as if he or she had not ceased to be such at the date of issuance. All of the Public Warrants shall initially be represented by one
or more book-entry certificates (each a “Book-Entry Warrant Certificate”). 

          2.2     Effect of Countersignature. Unless and until countersigned by the Warrant
Agent pursuant to this Agreement, a Warrant shall be invalid and of no effect and may not be exercised by the holder thereof. 

          2.3     Registration. 

                     (a)     Warrant Register. The Warrant Agent shall maintain books (the
“Warrant Register”) for the registration of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant
Agent shall issue and register such Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered to the Warrant Agent by the Company. All of the Public Warrants shall initially
be represented by one or more Book-Entry Warrant Certificates deposited with the Depository Trust Company (the “Depository”) and registered in the name of Cede &
Co., a nominee of the Depository. Ownership of beneficial interests in the Public Warrants shall be shown on, 

2 

and the transfer of such ownership shall be effected through, records maintained by (i) the Depository or its nominee for each Book-Entry Warrant Certificate, or (ii) institutions that have accounts with the Depository
(such institution, with respect to a Public Warrant in its account, a “Participant”). 

          If the Depository subsequently ceases to make its book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other arrangements
for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary to have the Public Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depository to
deliver to the Warrant Agent for cancellation each Book-Entry Warrant Certificate, and the Company shall instruct the Warrant Agent to deliver to the Depository definitive certificates representing the Warrants (“Definitive Warrant Certificates”). 

                     (b)     Beneficial Owner; Registered Holder. The term “beneficial owner” shall mean, on or after the Detachment Date (as defined below), any person in whose name ownership of a
beneficial interest in the Public Warrants evidenced by a Book-Entry Warrant Certificate is recorded in the records maintained by the Depository or its nominee, and prior to the Detachment Date, the person in whose name the Public Unit of which such
Public Warrant or part thereof was originally part of, as registered upon the register relating to such Public Units. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the
person in whose name such Warrant shall be registered upon the Warrant Register (“Registered Holder”) as the absolute owner of such Warrant (notwithstanding any
notation of ownership or other writing on the Warrant certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and neither the Company nor the Warrant Agent shall
be affected by any notice to the contrary. 

          2.4     Detachability of Warrants.

                    (a)     Public
Units. The securities comprising the Public
Units will not be  separately transferable until five Business Days (as defined
below) (or as soon as practicable thereafter) following the earlier to occur
of (i) the expiration or termination of the underwriters’ over-allotment
option or (ii) its exercise in  full (the “Detachment Date”),
subject in either case to the Company having filed a Current  Report on Form
8-K with the Securities and Exchange Commission containing an audited balance
sheet reflecting the receipt by the Company of the gross proceeds of the Initial
Public Offering including the proceeds received by the Company from the  exercise
of the underwriters’ over-allotment option, and having issued a press release
announcing when the separate trading of such securities will begin. For purposes
of this Agreement, “Business
Day” shall mean any day on which the
Depository is open for trading. 

                    (b)     Sponsor
Units. The securities comprising the Sponsor
Units will be separately  transferable at any time, subject to the transfer restrictions
on the Initial Sponsor Warrants described below in Section
2.5. 

3 

          2.5     Private Warrants. The Private Warrants shall have the same terms and be in the
same form as the Public Warrants, except that: 

	          	                    (i)      the
          Initial Sponsor Warrants may not be exercised unless and until the
          last sales price of the Common Stock exceeds $13.75 per share, as such
          price may be adjusted pursuant to Section
          4.3 (the “Floor
          Price”), for any 20 trading
          days within a 30 trading day period beginning 90 days after the consummation
          by the Company of a Business Combination (as defined below);

                           (ii)     the
          Private Warrants will be non-redeemable as long as they are held by
          the Sponsor or its Permitted Transferees, other than as part of a redemption
          of Sponsor Units if and to the extent the underwriters’ over-allotment
          options is not exercised in full;

                           (iii)     the
          Private Warrants may be exercised at the option of the holder on a
          cash or cashless basis;

                           (iv)     the
          Initial Sponsor Warrants may not be (and the Common Stock issuable
          upon exercise of such Warrants may not be) transferred, assigned or
          sold, directly or indirectly, other than to a Permitted Transferee,
          until 180 days after the consummation by the Company of a Business
          Combination; and

                           (v)      the
          Sponsor Warrants may not be (and the Common Stock issuable upon exercise
          of such Warrants may not be) transferred, assigned or sold, directly
          or indirectly, other than to a Permitted Transferee, until after the
    consummation by the Company of a Business Combination. 

“Business Combination” means the Company’s initial business combination, through a merger, capital stock exchange, asset acquisition,
stock purchase, reorganization or similar business combination, with one or more domestic or international operating businesses or assets meeting the conditions described in the Registration Statement and the Company’s
Amended and Restated Certificate of Incorporation at the time of the consummation
of the Initial Public Offering. 

“Permitted Transferees” means (i) any of the Company’s officers, directors and employees, any Affiliates or Family Members of such
individuals, any Affiliates of the Company, any Affiliates of the Sponsor and any officers, directors, members and employees of the Sponsor or such Affiliates, (ii) any charitable organization, (iii) any individual pursuant to a qualified domestic
relations order, (iv) if the transferor is a corporation, partnership or limited liability company, any stockholder, partner or member of the transferor, and (v) any individual or entity by virtue of laws or agreements governing descent or
distribution upon the death or dissolution of the transferor; provided, that, any such transferees
agree in writing to become subject to the same transfer restrictions as the transferor. 

4 

The term “Affiliate” has the meaning set forth in Rule 405 under the Securities Act (in effect on the date hereof). 

“Family Member” of a person means such person’s present spouse and/or domestic partner, parents, lineal ascendants or descendants or
any siblings of any of the foregoing, any descendants of any sibling of such person, or any estate planning vehicle formed primarily for the benefit of such person or any of the foregoing persons. 

ARTICLE III 

TERMS AND EXERCISE OF WARRANTS 

          3.1     Warrant Price. Each Warrant shall, when countersigned by the Warrant Agent,
entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement, to purchase from the Company the number of shares of Common Stock stated therein, at the price of $7.50 per whole share, subject to the
adjustments provided in Article IV hereof and in the last sentence of this Section 3.1. The term
“Warrant Price” as used in this Agreement refers to the price per share at which Common Stock may be purchased at the time a Warrant is exercised. The Company in its
sole discretion may lower the Warrant Price at any time prior to the Expiration Date (as defined below) for a period of not less than 20 Business Days; provided,
however, that any such reduction shall be identical in percentage terms among all of the Warrants.

          3.2     Duration of Warrants. A Warrant may be exercised only during the period (the
“Exercise Period”) commencing on the later of the consummation by the Company of a Business Combination and the first anniversary of the date of the final prospectus
that forms a part of the Registration Statement, and terminating at 5:00 p.m., New York time on the earlier to occur of (i) the fourth anniversary of the date of the final prospectus that forms a part of the Registration Statement and (ii) the date
fixed for redemption of the Warrants as provided in Article VI of this Agreement (“Expiration
Date”); provided, however, that, (i) the Public Warrants shall not be exercisable and the Company shall not be obligated to issue Common Stock in respect thereof unless, at the time a holder seeks to exercise such Public
Warrants, a prospectus relating to the Common Stock issuable upon exercise of the Public Warrants is current and the issuance of such Common Stock has been registered or qualified or deemed to be exempt under the securities laws of the state of
residence of the holder of such Warrants and (ii) in addition to the exercise conditions set forth in this Section 3.2, the Initial Sponsor Warrants may not be exercised unless
and until the last sales price of the Common Stock exceeds the Floor Price for any 20 trading days within a 30 trading day period beginning 90 days after the consummation by the Company of a Business Combination. Except with respect to the right to
receive the Redemption Price (as set forth in Article VI hereunder), each Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder
and all rights in respect thereof under this Agreement shall cease at the close of business on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided, however, that any extension of the duration of the Warrants must apply equally to all of 

5 

the Warrants. Should the Company wish to extend the Expiration Date of the Warrants, the Company shall provide advance notice to any stock exchange on which the Warrants are listed in accordance with the requirements of
such exchange. 

          3.3     Exercise of Warrants. 

                    (a)     Payment.
Subject to the provisions of the Warrant and this Agreement, a  Warrant, when
countersigned by the Warrant Agent, may be exercised by the Registered Holder
thereof by delivering, not later than 5:00 p.m., New York time, on any Business
Day during the Exercise Period (the “Exercise Date”) to the
Warrant Agent at the office of the Warrant Agent, or at the office of its successor
as Warrant Agent (i) the Definitive Warrant Certificate evidencing the Warrants
to be  exercised, or in the case of a Book-Entry Warrant Certificate, the Warrants
to be exercised (the “Book-Entry Warrants”) on the records of the Depositary to an account of
the Warrant Agent at the Depositary designated for such purpose in writing by
the Warrant Agent to the Depository from time to time, (ii) an election to purchase
in the  form attached hereto as part of Exhibit
A or Exhibit
B, as applicable, the shares of Common Stock
 underlying the Warrants to be exercised, properly completed and executed, or
in the case of a Book-Entry Warrant Certificate, properly delivered by the Participant
in accordance with the Depository’s procedures and (iii) the Warrant Price
for  each full share of Common Stock as to which the Warrants are exercised and
any and all applicable taxes due in connection with the exercise of the Warrants,
the exchange of the Warrants for the Common Stock, and the issuance of the Common
Stock in  full, in lawful money of the United States, by cash, by bank wire transfer
in immediately available funds or by certified check or bank draft payable to
the Company; provided,
however,
that the holders of the Private Warrants may pay the Warrant Price by surrendering
the Private Warrants for that number of shares of Common Stock equal to the quotient
 obtained by dividing (x) the product of the number of shares of Common Stock
underlying the Warrant, multiplied by the difference between the Fair Market
Value and the Warrant Price by (y) the Fair Market Value. The “Fair Market Value” means
the average last sales price of the Common Stock in the principal trading market
for the Common Stock as reported by any national securities exchange or quoted
on the  FINRA OTC Bulletin Board (or successor exchange), as the case may be,
for the 10 consecutive trading days ending on the third trading day preceding
the date the Private Warrants are exercised. 

	          	                    (i)     If
        any of (A) the Definitive Warrant Certificate or the Book-Entry Warrant
        Certificate, (B) the Election to Purchase or (C) the Warrant Price therefor,
        is received by the Warrant Agent after 5:00 p.m., New York time, on a
        specified day or if such day is not a Business Day, the Warrants will
        be deemed to be received and exercised on, and the applicable Exercise
        Date shall be the Business Day next succeeding such day. If the Warrants
        are received or deemed to be received after the Expiration Date, the
        exercise thereof will be null and void and any funds delivered to the
        Warrant Agent will be returned to the Registered Holder or the Participant,
        as the case may be, as soon as practicable. In no event will interest
        accrue on funds deposited with the Warrant Agent in respect of an exercise
    or attempted exercise of 

 

6 

	          	Warrants. The validity of any
          exercise of Warrants will be determined by the Company in its sole
          discretion and such determination will be final and binding upon the
          Registered Holder and the Warrant Agent. Neither the Company nor the
          Warrant Agent shall have any obligation to inform a Registered Holder
          of the invalidity of any exercise of Warrants. 

                           (ii)     The
          Warrant Agent shall deposit all funds received by it in payment of
          the Warrant Price in the account of the Company maintained with the
          Warrant Agent for such purpose and shall advise the Company at the
          end of each Business Day on which funds for the exercise of the Warrants
          are received and of the amount so deposited to its account. The Warrant
          Agent shall promptly confirm such telephonic advice to the Company
          in writing. 

                           (iii)     The
          Warrant Agent shall, by 11:00 a.m. New York time on the Business Day
          following the Exercise Date of any Warrant, advise the Company and
          the transfer agent and registrar in respect of (a) the shares of Common
          Stock (the “Shares”)
          issuable upon such exercise in accordance with the terms and conditions
          of this Agreement, (b) the instructions of each Registered Holder or
          Participant, as the case may be, with respect to delivery of the Shares
          issuable upon such exercise, and the delivery of Definitive Warrant
          Certificates, as appropriate, evidencing the balance, if any, of the
          Warrants remaining after such exercise, (c) in case of a Book-Entry
          Warrant Certificate, the notation that shall be made to the records
          maintained by the Depository, its nominee for each Book-Entry Warrant
          Certificate, or a Participant, as appropriate, evidencing the balance,
          if any, of the Warrants remaining after such exercise and (d) such
          other information as the Company or such transfer agent and registrar
          shall reasonably require. 

                           (iv)     The
          Company shall, by 5:00 p.m., New York time, on the third Business Day
          next succeeding the Exercise Date of any Warrant and the clearance
          of the funds in payment of the Warrant Price, execute, issue and deliver
          to the Warrant Agent, the Shares to which such Registered Holder or
          Participant, as the case may be, is entitled, in fully registered form,
          registered in such name or names as may be directed by such Registered
          Holder or the Participant, as the case may be. Upon receipt of such
          Shares, the Warrant Agent shall, by 5:00 p.m., New York time, on the
          fifth Business Day next succeeding such Exercise Date, transmit such
          Shares to or upon the order of the Registered Holder or the Participant,
          as the case may be. 

                           (v)     In
          lieu of delivering physical certificates representing the Shares issuable
          upon exercise, provided the Company’s transfer agent is participating
          in the Depository Fast Automated Securities Transfer program, the Company
          shall use its reasonable efforts to cause its transfer agent to electronically
          transmit the Shares issuable upon exercise to the Registered Holder
          or the Participant by crediting the account of the Registered Holder’s
          prime broker with the Depository or of the Participant through its
          Deposit Withdrawal Agent Commission system. The time periods for delivery
          described in the 

    

  7 

	          	immediately preceding paragraph
          shall apply to the electronic transmittals described herein. 

                           (vi)     The
          accrual of dividends, if any, on the Shares issued upon the valid exercise
          of any Warrant will be governed by the terms generally applicable to
          the Shares. Starting with the Exercise Date, the former holder of the
          Warrants exercised will be entitled to the benefits generally available
          to other holders of Shares and such former holder’s right to receive
          payments of dividends and any other amounts payable in respect of the
          Shares shall be governed by, and shall be subject to, the terms and
          provisions generally applicable to such Shares. 

                           (vii)     Subject
          to Section 4.7,
          Warrants may be exercised only in whole numbers of Shares. If fewer
          than all of the Warrants evidenced by a Warrant Certificate are exercised,
          a new Warrant Certificate for the number of unexercised Warrants remaining
          shall be executed by the Company and countersigned by the Warrant Agent
          as provided in Article II hereof,
          and delivered to the holder of this Warrant Certificate at the address
          specified on the books of the Warrant Agent or as otherwise specified
          by such Registered Holder. If fewer than all the Warrants evidenced
          by a Book-Entry Warrant Certificate are exercised, a notation shall
          be made to the records maintained by the Depository, its nominee for
          each Book-Entry Warrant Certificate, or a Participant, as appropriate,
          evidencing the balance of the Warrants remaining after such exercise. 

    

                     (b)     Issuance of Certificates. Notwithstanding the foregoing, and subject to
Section 7.4 of this Agreement, the Company shall not be obligated to deliver any securities pursuant to the exercise of a Warrant unless (i) a registration statement under the
Securities Act with respect to the issuance of Common Stock upon exercise of the Warrant is effective or (ii) in the opinion of counsel to the Company, the issuance of the Common Stock upon the exercise of the Warrants is exempt from the
registration requirements of the Securities Act and such securities are qualified for sale or exempt from qualification under applicable securities laws of the states or other jurisdictions in which the Registered Holders reside. Warrants may not be
exercised by, or securities issued to, any Registered Holder in any state in which such exercise would be unlawful. As a result of the provisions of this Section 3.3(b), any or
all of the Warrants may expire unexercised. In no event shall the Registered Holder of a Warrant be entitled to receive any monetary damages if the issuance of the shares of Common Stock underlying the Warrants has not been registered by the Company
pursuant to an effective registration statement or if a current prospectus is not available for delivery by the Warrant Agent; provided, that the Company has fulfilled its obligation to use its reasonable efforts to effect such registration and ensure a current prospectus is available for delivery by the Warrant Agent. 

                     (c)     Valid Issuance. All shares of Common Stock issued upon the proper exercise of
a Warrant in conformity with this Agreement shall be validly issued, fully paid and nonassessable. 

8 

                    (d)     Date
of Issuance. Each person in whose name any
such certificate for shares of  Common Stock is issued shall for all purposes
be deemed to have become the holder of record of such shares on the Exercise
Date in accordance with Section 3.3(a),
irrespective  of the date of delivery of such certificate to the holder, except
that, if delivery of the items set forth in Section
3.3(a) occurs after 5:00 p.m., New York
time, on any  Business Day during the Exercise Period, such person shall be deemed
to have become the holder of such shares at the close of business on the next
succeeding Business Day. 

          3.4     No Cash Settlement. Notwithstanding anything to the contrary contained in this
Agreement, under no circumstances will the Company be required to net cash settle the exercise of the Warrants.

ARTICLE IV 

ADJUSTMENTS 

          4.1     Stock Dividends; Split-Ups. If after the date hereof, and subject to the
provisions of Section 4.7, the number of outstanding shares of Common Stock is increased by a stock dividend payable in shares of Common Stock, or by a split up of shares of
Common Stock, or other similar event, then, on the effective date of such stock dividend, split up or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be increased in proportion to such increase in
outstanding shares of Common Stock. 

          4.2     Aggregation of Shares. If after the date hereof, and subject to the provisions
of Section 4.7, the number of outstanding shares of Common Stock is decreased by a consolidation, combination, reverse stock split or reclassification of shares of Common Stock
or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number of shares of Common Stock issuable on exercise of each Warrant shall be decreased in
proportion to such decrease in outstanding shares of Common Stock. 

          4.3     Adjustments in Warrant Price. Whenever the number of shares of Common Stock
purchasable upon the exercise of the Warrants is adjusted, as provided in Sections 4.1 and 4.2 above,
each of the Warrant Price and the Floor Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price and Floor Price, as the case may be, immediately prior to such adjustment by a fraction (x) the numerator of which shall be the
number of shares of Common Stock purchasable upon the exercise of the Warrants immediately prior to such adjustment and (y) the denominator of which shall be the number of shares of Common Stock so purchasable immediately thereafter; provided, that, with respect to any adjustment occurring prior to the consummation of the Initial Public
Offering, the Company may determine (with the consent of the Sponsor) not to adjust the Warrant Price and the Floor Price. 

          4.4     Replacement of Securities upon Reorganization, etc. In case of any
reclassification or reorganization of the outstanding shares of Common Stock (other 

9 

than a change covered by Section 4.1 or 4.2 hereof or that solely affects the
par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company is the continuing corporation and that does not
result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially as
an entirety in connection with which the Company is dissolved, the Registered Holders shall thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the Warrants and in lieu of the shares of
Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares of stock or other securities or property (including cash) receivable upon such
reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, by a Registered Holder of the number of shares of Common Stock of the Company obtainable upon exercise of the Warrants immediately
prior to such event; and if any reclassification also results in a change in shares of Common Stock covered by Sections 4.1 or 4.2, then such adjustment shall be made pursuant to Sections 4.1, 4.2, 4.3 and this Section 4.4. The provisions of this Section 4.4 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. 

          4.5     Extraordinary Dividends. If the Company, at any time during the Exercise
Period, shall pay a dividend or make a distribution in cash, securities or other assets to the holders of Common Stock (or other shares of the Company’s capital stock into which the Warrants are convertible), other than (i) as described in
Sections 4.1, 4.2 or 4.4, (ii)
regular quarterly or other periodic dividends, (iii) in connection with the conversion rights of the holders of Common Stock upon consummation by the Company of a Business Combination or (iv) in connection with the Company’s liquidation and the
distribution of its assets upon its failure to consummate a Business Combination (any such non-excluded event being referred to herein as an “Extraordinary Dividend”), then the Warrant Price and the Floor Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and/or the fair market value (as determined by the
Company’s Board of Directors, in good faith) of any securities or other assets paid on each share of Common Stock (or other shares of the Company’s capital stock into which the Warrants are convertible) in respect of such Extraordinary
Dividend. 

          4.6     Notices of Changes in Warrant. Upon every adjustment of the Warrant Price,
Floor Price or the number of shares issuable on exercise of a Warrant, the Company shall give written notice thereof to the Warrant Agent, which notice shall state the Warrant Price or Floor Price resulting from such adjustment and the increase or
decrease, if any, in the number of shares purchasable at such price upon the exercise of a Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event
specified in Sections 4.1, 4.2, 4.3, 4.4 or 4.5, then, in any such event, the Company shall give written notice to each
Registered Holder, at the last address set forth for such holder in the 

10 

Warrant Register, of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event. 

          4.7     No Fractional Shares. Notwithstanding any provision contained in this
Agreement to the contrary, the Company shall not issue fractional shares upon exercise of Warrants. If, by reason of any adjustment made pursuant to this Article IV or by
reason of any cashless exercise pursuant to Sections 3.3(a) or 6.1, the Registered Holder would be
entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round up to the nearest whole number the number of the shares of Common Stock to be issued to the Registered Holder.

          4.8     Form of Warrant. The forms of Warrants need not be changed because of any
adjustment pursuant to this Article IV, and Warrants issued after such adjustment may state the same Warrant Price and the same number of shares as is stated in the Warrants
initially issued pursuant to this Agreement. However, the Company may at any time in its sole discretion make any change in the form of Warrant that the Company may deem appropriate and that does not affect the substance thereof, and any Warrant
thereafter issued or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed. 

          4.9     Notice of Certain Transactions. In the event that the Company shall propose to
(a) offer the holders of its Common Stock rights to subscribe for or to purchase any securities convertible into shares of Common Stock or shares of stock of any class or any other securities, rights or options, (b) issue any rights, options or
warrants entitling the holders of Common Stock to subscribe for shares of Common Stock or (c) make a tender offer, redemption offer or exchange offer with respect to the Common Stock, the Company shall send to the Registered Holders a notice of such
proposed action or offer. Such notice shall be mailed to the Registered Holders at their addresses as they appear in the Warrant Register, which shall specify the record date for the purposes of such dividend, distribution or rights, or the date
such issuance or event is to take place and the date of participation therein by the holders of Common Stock, if any such date is to be fixed, and shall briefly indicate the effect of such action on the Common Stock and on the number and kind of any
other shares of stock and on other property, if any, and the number of shares of Common Stock and other property, if any, issuable upon exercise of each Warrant and the Warrant Price or Floor Price after giving effect to any adjustment pursuant to
this Article IV that would be required as a result of such action. Such notice shall be given as promptly as practicable after the Company’s Board of Directors has
determined to take any such action and (x) in the case of any action covered by clause (a) or (b) above at least 10 days prior to the record date for determining the holders of the Common Stock for purposes of such action or (y) in the case of any
other such action at least 20 days prior to the date of the taking of such proposed action or the date of participation therein by the holders of Common Stock, whichever shall be the earlier. 

11 

ARTICLE V 

TRANSFER AND EXCHANGE OF WARRANTS 

          5.1     Transfer of Warrants. Prior to the Detachment Date, the Public Warrants may be
transferred or exchanged only as part of the Public Units in which such Warrants are included, and only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Public Unit. For the avoidance of doubt, each transfer of a
Public Unit on the register relating to such Public Units shall operate also to transfer the Warrants included in such Public Unit. 

          5.2     Registration of Transfer. Subject to Section 5.3 below, the Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for transfer, properly
endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by
the Warrant Agent. The Warrants so cancelled shall be delivered by the Warrant Agent to the Company from time to time upon request. 

          5.3     Procedure for Surrender of Warrants. Warrants may be surrendered to the
Warrant Agent, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered, representing an
equal aggregate number of Warrants; provided, however, that except as otherwise provided herein or in
any Book-Entry Warrant Certificate, each Book-Entry Warrant Certificate may be transferred only in whole and only to the Depository, to another nominee of the Depository, to a successor depository, or to a nominee of a successor depository;
provided further, however,
that in the event that a Warrant surrendered for transfer bears a restrictive legend, the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange therefor until the Warrant Agent has received an opinion of counsel for the
Company stating that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend. Upon any such registration of transfer, the Company shall execute, and the Warrant Agent shall countersign and deliver, in
the name of the designated transferee a new Warrant certificate or Warrant certificates of any authorized denomination evidencing in the aggregate a like number of unexercised Warrants. 

          5.4     Fractional Warrants. The Warrant Agent shall not be required to effect any
registration of transfer or exchange that will result in the issuance of a Warrant certificate for a fraction of a Warrant. 

          5.5     Service Charges. No service charge shall be made for any exchange or
registration of transfer of Warrants. 

          5.6     Warrant Execution and Countersignature. The Warrant Agent is hereby authorized
to countersign and to deliver, in accordance with the terms of this 

12 

Agreement, the Warrants required to be issued pursuant to the provisions of this Article V, and the Company, whenever required by the Warrant Agent,
shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose. 

ARTICLE VI 

REDEMPTION 

          6.1     Redemption. Subject to Section
6.4 hereof, not less than all of the outstanding Warrants (other than any Private Warrants that are held by the Sponsor or any Permitted Transferees) may be redeemed, at the option of the Company, at any time
after they become exercisable and prior to their expiration, at the office of the Warrant Agent, upon the notice referred to in Section 6.2, at the price of $0.01 per Warrant
(the “Redemption Price”); provided, however, that the last sales price of the Common Stock has been equal to or greater than the Floor Price on each of 20 trading days within any 30 trading day period ending three Business Days prior
to the date on which notice of redemption is given; and provided, further that with respect to the Public Warrants only, such Warrants (and the Common Stock issuable upon the exercise of such Warrants) are covered by an effective
registration statement from the date of notice of redemption through the date fixed for redemption. If the foregoing conditions are satisfied, and such Warrants are called for redemption, each Registered Holder will be entitled to exercise their
Warrants prior to the date scheduled for redemption. In the event the Company calls any such Warrants for redemption pursuant to this Section 6.1, the Company shall have the
option to require all (but not part) of the holders of those Warrants who elect to exercise their Warrants prior to the date scheduled for redemption to exercise the Warrants on a cashless basis. If the Company requires the Registered Holders of
such Warrants to exercise on a cashless basis, each holder of such Warrants shall pay the Warrant Price by surrendering such Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number
of shares of Common Stock underlying the Warrants, multiplied by the difference between the Redemption Fair Market Value and the Warrant Price of the Warrants by (y) the Redemption Fair Market Value. The “Redemption Fair Market Value” shall mean the average reported last sales price of the Common Stock in the principal trading market for the Common Stock as reported by any national securities
exchange or quoted on the FINRA OTC Bulletin Board (or successor exchange), as the case may be, for the 10 consecutive trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the Registered Holders
of such Warrants. 

          6.2     Date Fixed for, and Notice of, Redemption. In the event the Company shall
elect to redeem all of the outstanding Warrants (other than any Private Warrants that are held by the Sponsor or any Permitted Transferees) pursuant to Section 6.1 (the
“Redeemable Warrants”), the Company shall fix a date for the redemption. Notice of redemption shall be mailed by first class mail, postage prepaid, by the Company not
less than 30 days prior to the date fixed for redemption to the Registered Holders of the Redeemable Warrants at their last addresses as they shall appear in the Warrant Register. Any notice mailed in the manner herein provided shall 

13 

be conclusively presumed to have been duly given on the date sent whether or not the Registered Holder received such notice. 

          6.3     Exercise After Notice of Redemption. The Redeemable Warrants may be exercised,
for cash or, if required by the Company, on a cashless basis, in accordance with Section 6.1 of this Agreement at any time after notice of redemption shall have been given by
the Company pursuant to Section 6.2 hereof and prior to the time and date fixed for redemption. On and after the redemption date, the Registered Holder of the Redeemable
Warrants shall have no further rights except to receive the Redemption Price upon surrender of the Redeemable Warrants. 

          6.4     Outstanding Warrants Only. The Company understands that the redemption rights
provided for by this Article VI apply only to outstanding Redeemable Warrants. To the extent a person holds rights to purchase Redeemable Warrants, such purchase rights shall
not be extinguished by redemption. However, once such purchase rights are exercised, the Company may redeem the Redeemable Warrants issued upon such exercise, provided
that the criteria for redemption are met, including the opportunity of the Redeemable Warrant holders to exercise prior to redemption pursuant to Section 6.3. 

ARTICLE VII 

OTHER PROVISIONS RELATING TO RIGHTS OF HOLDERS OF WARRANTS 

          7.1     No Rights as Stockholder. A Warrant does not entitle the Registered Holder
thereof to any of the rights of a stockholder of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights, to vote or to consent or to receive notice as stockholders in
respect of the meetings of stockholders for the election of directors of the Company or any other matter. 

          7.2     Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost,
stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof), issue a new
Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated or destroyed. Any such new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or
destroyed Warrant shall be at any time enforceable by anyone. 

          7.3     Reservation of Common Stock. The Company shall at all times reserve and keep
available a number of its authorized but unissued shares of Common Stock that will be sufficient to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement. 

14 

          7.4     Registration of Common Stock. If the Company consummates an Initial Public
Offering, the Company agrees that prior to the commencement of the Exercise Period, it shall file with the Securities and Exchange Commission a post-effective amendment to the Registration Statement, or a new registration statement, for the
registration under the Securities Act of, and it shall take such action as may be necessary to qualify for sale, in those states in which the Public Warrants were initially offered by the Company, the issuance of the Common Stock issuable upon
exercise of the Public Warrants. In either case, the Company shall use its reasonable efforts to cause the same to become effective on or prior to the commencement of the Exercise Period and to maintain the effectiveness of such registration
statement until the expiration of the Public Warrants in accordance with the provisions of this Agreement. 

ARTICLE VIII 

CONCERNING THE WARRANT AGENT AND OTHER MATTERS 

          8.1     Payment of Taxes. The Company shall from time to time promptly pay all taxes
and charges that may be imposed upon the Company or the Warrant Agent in respect of the issuance or delivery of shares of Common Stock upon the exercise of the Warrants, but the Company shall not be obligated to pay any transfer taxes in respect of
the Warrants or of such shares of the Common Stock. 

          8.2     Resignation, Consolidation, or Merger of Warrant Agent. 

                    (a)     Appointment
of Successor Warrant Agent. The Warrant
Agent, or any successor to  it hereafter appointed, may resign its duties and
be discharged from all further duties and liabilities hereunder after giving
60 days’ notice in writing to the Company. If the office of the Warrant
Agent becomes vacant by resignation or  incapacity to act or otherwise, the Company
shall appoint in writing a successor Warrant Agent in place of the Warrant Agent.
If the Company shall fail to make such appointment within a period of 30 days
after it has been notified in writing of such  resignation or incapacity by the
Warrant Agent or any Registered Holder (who shall, with such notice, submit his
Warrant for inspection by the Company), then the holder of any Warrant may apply
to the Supreme Court of the State of New York for the  County of New York for
the appointment of a successor Warrant Agent at the Company’s cost. Any
successor Warrant Agent, whether appointed by the Company or by such court, shall
be a corporation organized and existing under the laws of the State of New York,
in good standing and having its principal office in the  Borough of Manhattan,
City and State of New York, and authorized under such laws to exercise corporate
trust powers and subject to supervision or examination by federal or state authority.
After appointment, any successor Warrant Agent shall be  vested with all the
authority, powers, rights, immunities, duties, and obligations of its predecessor
Warrant Agent with like effect as if originally named as Warrant Agent hereunder,
without any further act or deed; but if for any reason it becomes  necessary
or appropriate, the predecessor Warrant Agent shall execute and deliver, at the
expense of the Company, an instrument transferring to such successor Warrant
Agent all the authority, powers, and rights of such predecessor 

15 

Warrant Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming
to such successor Warrant Agent all such authority, powers, rights, immunities, duties, and obligations. 

                    (b)     Notice
of Successor Warrant Agent. In the event
a successor Warrant Agent  shall be appointed, the Company shall give notice
thereof to the predecessor Warrant Agent and the transfer agent for the Common
Stock not later than the effective date of any such appointment. 

                   (c)     Merger
or Consolidation of Warrant Agent. Any corporation
or other entity into  which the Warrant Agent may be merged or with which it
may be consolidated or any corporation resulting from any merger or consolidation
to which the Warrant Agent shall be a party shall be the successor Warrant Agent
under this Agreement without  any further act. 

          8.3     Fees and Expenses of Warrant Agent. 

                    (a)     Remuneration.
The Company agrees to pay the Warrant Agent reasonable  remuneration for its
services as such Warrant Agent hereunder and shall reimburse the Warrant Agent
upon written demand for all reasonable expenditures that the Warrant Agent may
reasonably incur in the execution of its duties hereunder. 

                    (b)     Further
Assurances. The Company agrees to perform,
execute, acknowledge and  deliver or cause to be performed, executed, acknowledged
and delivered all such further and other acts, instruments and assurances as
may reasonably be required by the Warrant Agent for the carrying out or performing
of the provisions of this  Agreement. 

          8.4     Liability of Warrant Agent. 

                    (a)     Reliance
on Company Statement. Whenever in the performance
of its duties under  this Agreement, the Warrant Agent shall deem it necessary
or desirable that any fact or matter be proved or established by the Company
prior to taking or suffering any action hereunder, such fact or matter (unless
other evidence in respect thereof  be herein specifically prescribed) may be
deemed to be conclusively proved and established by a statement signed by the
Chairman of the Board of Directors, Vice Chairman, President, Chief Financial
Officer, Treasurer, Chief Legal Officer, Secretary  or Assistant Secretary of
the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon
such statement for any action taken or suffered in good faith by it pursuant
to the provisions of this Agreement. 

                    (b)     Indemnity.

	          	                  (i)     The
        Warrant Agent shall be liable hereunder only for its own negligence,
        willful misconduct or bad faith. The Company agree s to indemnify the
    Warrant Agent and save it harmless against any and all liabilities, 

16 

	          	including judgments, costs
          and reasonable counsel fees, for anything done or omitted by the Warrant
          Agent in the execution of this Agreement except as a result of the
          Warrant Agent’s negligence, willful misconduct or bad faith. 

                (ii)     In
          case any action arising out of this Agreement is brought against the
          Warrant Agent, the Company will be entitled to participate therein
          and, to the extent that it may wish, to assume the defense thereof,
          and after notice from the Company to the Warrant Agent of its election
          so to assume the defense, the Company will not be liable to the Warrant
          Agent under this Section 8.4(b) for
          any legal or other expenses subsequently incurred by the Warrant Agent
          in connection with the defense thereof. The Warrant Agent shall not,
          without the prior written consent of the Company, effect any settlement
          of any pending or threatened action hereunder. 

    

                     (c)     Exclusions.
    The Warrant Agent shall have no responsibility with respect to the  validity
    of this Agreement or with respect to the validity or execution of any Warrant
    (except its countersignature thereof); nor shall it be responsible for any
    breach by the Company of any covenant or condition contained in this Agreement
    or in  any Warrant; nor shall it be responsible to make any adjustments required
    under the provisions of Article IV hereof
    or responsible for the manner, method, or amount of any such  adjustment
    or the ascertaining of the existence of facts that would require any such
    adjustment; nor shall it by any act hereunder be deemed to make any representation
    or warranty as to the authorization or reservation of any shares of Common
    Stock  to be issued pursuant to this Agreement or any Warrant or as to whether
    any shares of Common Stock will when issued be valid and fully paid and nonassessable. 

          8.5     Acceptance of Agency. The Warrant Agent hereby accepts the agency established
by this Agreement and agrees to perform the same upon the terms and conditions herein set forth and among other things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company,
all moneys received by the Warrant Agent for the purchase of shares of the Company’s Common Stock through the exercise of Warrants. 

          8.6     Waiver. The Warrant Agent hereby waives any and all right or set-off of any
and all title, interest or claim of any kind (“Claim”) in or to any distribution of the Trust Account (as defined in that certain Investment Management Trust
Agreement to be entered into by and between the Company and Wilmington Trust Company as trustee thereunder), and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the funds in the Trust Account for any
reason whatsoever including, without limitation, pursuant to Section 8.4(b) hereunder, and to pursue any such Claims solely against the Company. 

17 

ARTICLE IX 

MISCELLANEOUS PROVISIONS 

          9.1     Successors. All the covenants and provisions of this Agreement by or for the
benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective successors and assigns. 

          9.2     Notices. Any notice, statement or demand authorized by this Agreement to be
given or made by the Warrant Agent or by any Registered Holder to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five days after deposit
of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows: 

Trian Acquisition I Corp.

280 Park Avenue

41st Floor

New York, New York 10017

Attn: Chief Legal Officer 

          Any notice, statement or demand authorized by this Agreement to be given or made by any Registered Holder or by the Company to or on the Warrant Agent shall be sufficiently given when so
delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the
Company), as follows: 

American Stock Transfer & Trust Company

59 Maiden
Lane

New York, New York 10038

Attn: George Karfunkel 

          9.3     Applicable Law. The validity, interpretation and performance of this Agreement
and of the Warrants shall be governed in all respects by the laws of the State of New York, without giving effect to conflict of laws. The Company and the Warrant Agent hereby agree that any action, proceeding or claim against it arising out of or
relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
shall be exclusive. The Company and the Warrant Agent hereby waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any such process or summons to be served upon the Company or the Warrant Agent may
be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage prepaid, addressed to it at the address set forth in Section 9.2
hereof. Such mailing shall be deemed personal service and shall be legal and binding upon the 

18 

Company in any action, proceeding or claim; provided, that, such service
shall not preclude any other manner of service permitted by law. 

          9.4     Persons Having Rights under this Agreement. Nothing in this Agreement
expressed and nothing that may be implied from any of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and the Registered Holders of the Warrants, any
right, remedy or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise or agreement hereof. All covenants, conditions, stipulations, promises and agreements contained in this Agreement shall be for the sole
and exclusive benefit of the parties hereto and their successors and assigns and of the Registered Holders of the Warrants. 

          9.5     Examination of the Warrant Agreement. A copy of this Agreement shall be
available at all reasonable times at the office of the Warrant Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to submit his Warrant
for inspection by it. 

          9.6     Counterparts. This Agreement may be executed in any number of counterparts and
each of such counterparts shall for all purposes be deemed to be an original and all such counterparts shall together constitute but one and the same instrument. 

          9.7     Effect of Headings. The Section headings herein are for convenience only and
are not part of this Agreement and shall not affect the interpretation thereof. 

          9.8     Amendments. This Agreement may be amended by the parties hereto without the
consent of any Registered Holder for the purpose of curing any ambiguity, or of curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions with respect to matters or questions arising
under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the interest of the Registered Holders. All other modifications or amendments, including any amendment to increase the Warrant
Price or shorten the Exercise Period, shall require the written consent of the Registered Holders of a majority of the then outstanding Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the
Exercise Period in accordance with Sections 3.1 and 3.2, respectively, without such consent.

          9.9     Severability. This Agreement shall be deemed severable, and the invalidity or
unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties
hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable. 

19 

          9.10     Entire Agreement. This Agreement constitutes the entire understanding of the
parties and supersedes all prior agreements, understandings, arrangements, promises and commitments, whether written or oral, express or implied, relating to the subject matter hereof, and all such prior agreements, understandings, arrangements,
promises and commitments are hereby canceled and terminated. 

[Remainder of Page Intentionally Left Blank] 

20 

          IN WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the date first above written. 

	 	TRIAN ACQUISITION I CORP. 

       By: /s/ Greg Essner                                    

              Name: Greg
          Essner 

              Title:   Treasurer, Chief Financial 

                          Officer & Secretary 

       AMERICAN STOCK TRANSFER & 

        TRUST
            COMPANY 

       By: /s/ Herb Lemmer                                 

             Name: Herb
    Lemmer 

             Title:   Senior Vice President 

 

21 

EXHIBIT A 

Form of Public Warrant 

          The shares of Common Stock issuable upon exercise of the Warrants represented by this Warrant Certificate have not been registered under the Securities Act of 1933, as amended. The Company
shall not be obligated to deliver any such shares unless (i) a registration statement under the Securities Act with respect to the issuance of such shares upon exercise of the Warrants is effective or (ii) in the opinion of counsel to the Company,
such registration statement is not required. 

          The securities represented by this Warrant Certificate (including the securities issuable upon the exercise of the Warrant) are subject to the terms and conditions set forth in the Warrant
Agreement dated as of November 1, 2007, by and between the Company and the Warrant Agent (the “Warrant Agreement”). Copies of such agreement may be obtained by the holder hereof at the Warrant Agent’s principal place of business
without charge. 

SPECIMEN WARRANT CERTIFICATE 

	
NUMBER
		 
		
____________ WARRANTS
	
	
____________
-
		 
		 

	

THIS WARRANT WILL BE VOID IF NOT EXERCISED PRIOR TO
5:00 p.m.

NEW YORK CITY TIME, ON THE EXPIRATION DATE 

TRIAN ACQUISITION I CORP. 

CUSIP ______________

WARRANT 

THIS CERTIFIES THAT, for value received 

is the registered holder of such number of Warrants set forth above (the “Warrants”), each such Warrant expiring on the fourth anniversary
of the date of the final prospectus that forms a part of the Registration Statement (unless earlier redeemed in accordance with the terms hereof) and entitling the holder thereof to purchase one fully paid and non-assessable share of Common Stock,
par value $0.0001 per share (“Common Stock”), of Trian Acquisition I Corp., a Delaware corporation (the “Company”). The Warrant entitles the holder thereof to purchase from the Company, commencing on the later of (i) the consummation by the Company of a Business Combination or (ii) the first
anniversary of the date of the final prospectus that forms a part of the Registration Statement, such number of shares of Common Stock of the Company at the price of $7.50 per share (as such price may be adjusted), upon surrender of this Warrant
Certificate and payment of the Warrant Price at the office or agency of the Warrant 

A–1 

Agent, American Stock Transfer & Trust Company (such payment to be made to the Warrant Agent in lawful money of the United States, by cash, by bank wire transfer in immediately available funds, or by certified check or
bank draft payable to the Company or on a cashless basis at the option of the Company as described below), but only subject to the conditions set forth herein and in the Warrant Agreement. The Warrant Agreement provides that upon the occurrence of
certain events the Warrant Price, the Floor Price and the number of shares of Common Stock purchasable upon the exercise of each Warrant may, subject to certain conditions, be adjusted. The term Warrant Price as used in this Warrant Certificate
refers to the price per share at which shares of Common Stock may be purchased at the time the Warrant is exercised. 

          No fraction of a share will be issued upon any exercise of a Warrant. If, upon exercise of a Warrant, a holder would be entitled to receive a fractional interest in a share of Common Stock, the
Company shall, upon exercise, round up to the nearest whole number the number of shares of Common Stock to be issued to the warrant holder. 

          Upon any exercise of the Warrant for less than the total number of full shares of Common Stock provided for herein, there shall be issued to the Registered Holder hereof or his assignee a new
Warrant Certificate covering the number of shares of Common Stock for which the Warrant has not been exercised. 

          Warrant Certificates, when surrendered at the office or agency of the Warrant Agent by the Registered Holder hereof in person or by attorney duly authorized in writing, may be exchanged in the
manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants.

          Upon due presentment for registration of transfer of the Warrant Certificate at the office or agency of the Warrant Agent, a new Warrant Certificate or Warrant Certificates of like tenor and
evidencing in the aggregate a like number of Warrants shall be issued to the transferee in exchange for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any applicable tax or other
governmental charge. 

          The Company and the Warrant Agent may deem and treat the Registered Holder as the absolute owner of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon
made by anyone), for the purpose of any exercise hereof, of any distribution to the Registered Holder, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. 

          This Warrant does not entitle the Registered Holder to any of the rights of a stockholder of the Company. 

          Subject to Section 6.4 of the Warrant Agreement, the Company may redeem all, but not less than all, of the Public
Warrants, at the option of the Company, at 

A–2 

any time after such Warrants become exercisable and prior to their expiration, at the office of the Warrant Agent, upon the notice referred to in Section 6.2 of the Warrant Agreement, at the price of $0.01 per Warrant (the “Redemption Price”); provided, however, that the last sales price of the Common Stock has been equal to or greater than the Floor Price on each of 20 trading days within any 30 trading
day period ending three Business Days prior to the date on which notice of redemption is given; and provided, further that such Warrants (and the Common Stock issuable upon the exercise of such Warrants) are covered by an effective registration statement from the date of notice
of redemption through the date fixed for redemption. If the foregoing conditions are satisfied, and the Warrants are called for redemption, each Registered Holder will be entitled to exercise their Warrants prior to the date scheduled for
redemption. In the event the Company calls the Warrants for redemption pursuant to Section 6.1 of the Warrant Agreement, the Company shall have the option to require all (but
not part) of the holders of those Warrants who elect to exercise their Warrants prior to the date scheduled for redemption to exercise the Warrants on a cashless basis. If the Company requires holders of the Warrants to exercise the Warrants on a
cashless basis, the holder of such Warrants shall pay the Warrant Price by surrendering such Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock
underlying the Warrants, multiplied by the difference between the Redemption Fair Market Value and the Warrant Price of the Warrants by (y) the Redemption Fair Market Value. Any Warrant either not exercised or tendered back to the Company by the end
of the date specified in the notice of redemption shall be canceled on the books of the Company and have no further value except for the $0.01 redemption price.

          Capitalized terms used herein but not defined shall have the meaning set forth in the Warrant Agreement. 

	 	TRIAN ACQUISITION I CORP. 

       By:                                                                  

       Name: 

       Title:

       AMERICAN STOCK TRANSFER & 

  TRUST COMPANY 

       By:                                                                  

       Name: 

       Title:

 

A–3 

ELECTION TO PURCHASE 

To Be Executed by the Registered Holder in Order to Exercise Warrants 

          The
undersigned registered holder irrevocably elects to exercise _______________________
Warrants represented by this Warrant Certificate, and to purchase the shares
of Common Stock issuable upon the exercise of such Warrants, and requests that
Certificates for such shares shall be issued in the name of 

(PLEASE TYPE OR PRINT NAME AND ADDRESS) 

 

(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER) 

and be delivered to 

	 

	
      (PLEASE PRINT OR TYPE NAME AND ADDRESS)
	    

and, if such number of Warrants shall not be all the Warrants evidenced by this Warrant Certificate, that a new Warrant Certificate for the balance of such Warrants be registered in the name of, and delivered to, the
registered holder at the address stated below: 

	
Dated:
		 
	 
		 

	
	 	 	 
	 

		 
		
(SIGNATURE)
	
	 	 	 
	 	 	 
	 

		 
		
(ADDRESS)
	
	 	 	 
	 	 	  
	 	 	 
	 

	
	 

		 
		
(TAX IDENTIFICATION NUMBER)
	

ASSIGNMENT 

To Be Executed by the Registered Holder in Order to Assign Warrants 

For Value Received, __________________________________
hereby sells, assigns, and transfers unto 

 

(PLEASE TYPE OR PRINT NAME AND
    ADDRESS)  

 

(SOCIAL SECURITY OR TAX IDENTIFICATION
    NUMBER) 

 and be delivered to 

	 

	(PLEASE
          PRINT OR TYPE NAME AND ADDRESS) 

  ___________________________________
  of the Warrants represented by this Warrant Certificate, and hereby irrevocably
  constitute and appoint 

  

  _________________________________________________________
  Attorney to
transfer this Warrant Certificate on the books of the Company, with full power
of substitution in the premises. 

	
Dated:
		 
		 

	
	 	 	 
	 

		 
		
(SIGNATURE)
	

The signature to the assignment of the subscription form must correspond to the name written upon the face of this warrant certificate in every particular, without alteration or enlargement or any change whatsoever, and
must be guaranteed by a commercial bank or trust company or a member firm of the American Stock Exchange, New York Stock Exchange, Pacific Stock Exchange or Chicago Stock Exchange. 

EXHIBIT B 

Form of Private Warrant 

          The securities represented by this Warrant Certificate (including the securities issuable upon exercise of the Warrant) have not been registered under the Securities Act of 1933, as amended.
The securities may not be sold, offered for sale, pledged or hypothecated in the absence of an effective registration statement as to the securities under the Securities Act or an opinion of counsel satisfactory to the Company that such registration
statement is not required. 

          The securities represented by this Warrant Certificate (including the securities issuable upon the exercise of the Warrant) are subject to the terms and conditions, including certain
restrictions on transfer, set forth in the Warrant Agreement dated as of November 1, 2007, by and between the Company and the Warrant Agent. Copies of such agreement may be obtained by the holder hereof at the Warrant Agent’s principal place of
business without charge. 

SPECIMEN WARRANT CERTIFICATE 

	
NUMBER
		 
		
      _______________ WARRANTS
	    

	
____________-
		 
		 

	

THIS WARRANT WILL BE VOID IF NOT EXERCISED PRIOR TO 5:00 p.m. 

NEW YORK CITY TIME, ON THE EXPIRATION DATE 

TRIAN ACQUISITION I CORP. 

CUSIP ______________

WARRANT 

THIS CERTIFIES THAT, for value received 

is the registered holder of such number of Warrants set forth above (the “Warrants”), each such Warrant expiring on the fourth anniversary of the date of the final prospectus that forms a part of the Registration
Statement (unless earlier redeemed in accordance with the terms hereof) and entitling the holder thereof to purchase one fully paid and non-assessable share of Common Stock, par value $0.0001 per share (“Common Stock”), of Trian Acquisition I Corp., a Delaware corporation (the “Company”). The Warrant entitles the
holder thereof to purchase from the Company, commencing on the later of (i) the consummation by the Company of a Business Combination or (ii) the first anniversary of the date of the final prospectus that forms a part of the Registration Statement,
such number of shares of Common Stock of the Company at the price of $7.50 per share (as such price may be adjusted), upon surrender of this Warrant Certificate and payment of the Warrant Price at the office or agency of the Warrant Agent, American
Stock Transfer & Trust Company (such payment to be made to the 

B–1 

Warrant Agent in lawful money of the United States, by cash, by bank wire transfer in immediately available funds, or by certified check or bank draft payable to the Company or on a cashless basis as described in
Section 3.3(a) of the Warrant Agreement and below), but only subject to the conditions set forth herein and in the Warrant Agreement; provided, that the Initial Sponsor Warrants may not be exercised unless and until the last sales price of the Common Stock
exceeds the Floor Price for any 20 trading days within a 30 day trading period beginning 90 days after a Business Combination. The Warrant Agreement provides that upon the occurrence of certain events the Warrant Price, the Floor Price and the
number of shares of Common Stock purchasable upon the exercise of each Warrant, may, subject to certain conditions, be adjusted. The term Warrant Price as used in this Warrant Certificate refers to the price per share at which shares of Common Stock
may be purchased at the time the Warrant is exercised. 

          No fraction of a share of Common Stock will be issued upon any exercise of a Warrant. If, upon exercise of a Warrant, a holder would be entitled to receive a fractional interest in a share of
Common Stock, the Company shall, upon exercise, round up to the nearest whole number the number of shares to be issued to the Warrant holder. 

          Upon any exercise of the Warrant for less than the total number of full shares of Common Stock provided for herein, there shall be issued to the Registered Holder hereof or his assignee a new
Warrant Certificate covering the number of shares of Common Stock for which the Warrant has not been exercised. 

          Warrant Certificates, when surrendered at the office or agency of the Warrant Agent by the Registered Holder hereof in person or by attorney duly authorized in writing, may be exchanged in the
manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor and evidencing in the aggregate a like number of Warrants.

          Upon due presentment for registration of transfer of the Warrant Certificate at the office or agency of the Warrant Agent, a new Warrant Certificate or Warrant Certificates of like tenor and
evidencing in the aggregate a like number of Warrants shall be issued to the transferee in exchange for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any applicable tax or other
governmental charge. 

          The Company and the Warrant Agent may deem and Registered Holder as the absolute owner of this Warrant Certificate (notwithstanding any notation of ownership or other writing hereon made by
anyone), for the purpose of any exercise hereof, of any distribution to the Registered Holder, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. 

          This Warrant does not entitle the holder to any of the rights of a stockholder of the Company. 

B–2 

          Subject to Section 6.4 of the Warrant Agreement, the Company may redeem all, but not less than all, of the Private
Warrants that are not held by the Sponsor or any Permitted Transferees, at the option of the Company, at any time after the Warrants become exercisable and prior to their expiration, at the office of the Warrant Agent, upon the notice referred to in
Section 6.2 of the Warrant Agreement, at the price of $0.01 per Warrant (the “Redemption Price”); provided, however, that the last sales price of the Common Stock has been equal
to or greater than the Floor Price, on each of 20 trading days within any 30 trading day period ending three Business Days prior to the date on which notice of redemption is given. If the foregoing conditions are satisfied, and the Warrants are
called for redemption, each Registered Holder will be entitled to exercise their Warrants prior to the date scheduled for redemption. In the event the Company calls the Warrants for redemption pursuant to Section
6.1 of the Warrant Agreement, the Company shall have the option to require all (but not part) of the holders of those Warrants who elect to exercise their Warrants prior to the date scheduled for redemption to
exercise the Warrants on a cashless basis. If the Company requires holders of the Warrants to exercise the Warrants on a cashless basis, the holder of such Warrants shall pay the Warrant Price by surrendering such Warrants for that number of shares
of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the difference between the Redemption Fair Market Value and the Warrant Price of the Warrants
by (y) the Redemption Fair Market Value. Any Warrant either not exercised or tendered back to the Company by the end of the date specified in the notice of redemption shall be canceled on the books of the Company and have no further value except for
the $0.01 redemption price.

          Capitalized terms used herein but not defined shall have the meaning set forth in the Warrant Agreement. 

	 	TRIAN ACQUISITION
            I CORP. 

       By:                                                                                           

          Name: 

          Title:

       AMERICAN STOCK TRANSFER & 

  TRUST COMPANY 

       By:                                                                                           

          Name: 

          Title:

 

B–3 

ELECTION TO PURCHASE 

To Be Executed by the Registered Holder in Order to Exercise Warrants 

          The
undersigned registered holder irrevocably elects to exercise _________________
Warrants represented by this Warrant Certificate, and to purchase the shares
of Common Stock issuable  upon the exercise of such Warrants, and requests that
Certificates for such shares shall be issued in the name of

(PLEASE TYPE OR PRINT NAME AND ADDRESS)
  

  

 

(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER) 

and be delivered to 

	 

	(PLEASE
          PRINT OR TYPE NAME AND ADDRESS) 

and, if such number of Warrants shall not be all the Warrants evidenced by this Warrant Certificate, that a new Warrant Certificate for the balance of such Warrants be registered in the name of, and delivered to, the
registered holder at the address stated below: 

	Dated: 	 
	 	 
	 	 	 
	 	 	(SIGNATURE) 
	 	 	 
	 	 	 
	 	 	(ADDRESS) 
	 	 	 
	 	 	 
	 	 	 
	 
	 	 	(TAX IDENTIFICATION NUMBER) 

ASSIGNMENT 

To Be Executed by the Registered Holder in Order to Assign Warrants 

For Value Received, _________________________________ hereby sells, assigns, and transfers unto

(PLEASE TYPE OR PRINT NAME AND ADDRESS)
  

  

 

(SOCIAL SECURITY OR TAX IDENTIFICATION NUMBER) 

and be delivered to 

	 

	
      (PLEASE PRINT OR TYPE NAME AND ADDRESS)
	    

          ___________________________________
of the Warrants represented by this Warrant Certificate, and hereby irrevocably
constitute and appoint

_______________________________________________________
 Attorney to transfer this Warrant Certificate on the books of the Company, with
full power of substitution in the premises. 

	
Dated:
		 
		 

	
	 	 	 
	 

		 
		
(SIGNATURE)
	

The signature to the assignment of the subscription form must correspond to the name written upon the face of this warrant certificate in every particular, without alteration or enlargement or any change whatsoever, and
must be guaranteed by a commercial bank or trust company or a member firm of the American Stock Exchange, New York Stock Exchange, Pacific Stock Exchange or Chicago Stock Exchange.-- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

Exhibit 10.8 

[Form of Indemnification Agreement]

 

 

INDEMNIFICATION AGREEMENT 

by and among 

TRIAN ACQUISITION I CORP., 

 

TRIAN FUND MANAGEMENT, L.P., 

  as Guarantor 

 

and 

 

_________________, 

as Indemnitee 

 

_____________________________

Dated as of ____________, 2007

_____________________________

	 

 

	
TABLE OF CONTENTS
	
	 

		 

		 
		
Page
	
	 	 	 	 
	
ARTICLE 1
		
DEFINITIONS
		 
		
2
	
	 	 	 	 
	
ARTICLE 2
		
INDEMNITY IN THIRD-PARTY PROCEEDINGS
		 
		
6
	
	 	 
	
ARTICLE 3
		
INDEMNITY IN PROCEEDINGS BY OR IN THE RIGHT OF THE
	
	 

		
COMPANY
		 
		
6
	
	 	 	 	 
	
ARTICLE 4
		
INDEMNIFICATION FOR EXPENSES OF A PARTY WHO IS
		 
		 

	
	 

		
WHOLLY OR PARTLY SUCCESSFUL
		 
		
7
	
	 	 	 	 
	
ARTICLE 5
		
INDEMNIFICATION FOR EXPENSES OF A WITNESS
		 
		
7
	
	 	 	 	 
	
ARTICLE 6
		
ADDITIONAL INDEMNIFICATION, HOLD HARMLESS AND
		 
		 

	
	 

		
EXONERATION RIGHTS
		 
		
7
	
	 	 	 	 
	
ARTICLE 7
		
CONTRIBUTION IN THE EVENT OF JOINT LIABILITY
		 
		
8
	
	 	 	 	 
	
ARTICLE 8
		
EXCLUSIONS
		 
		
8
	
	 	 	 	 
	
ARTICLE 9
		
ADVANCES OF EXPENSES; SELECTION OF LAW FIRM
		 
		
9
	
	 	 	 	 
	
ARTICLE 10
		
PROCEDURE FOR NOTIFICATION; DEFENSE OF CLAIM;
		 
		 

	
	 

		
SETTLEMENT
		 
		
10
	
	 	 	 	 
	
ARTICLE 11
		
PROCEDURE UPON APPLICATION FOR INDEMNIFICATION
		 
		
11
	
	 	 	 	 
	
ARTICLE 12
		
ESTABLISHMENT OF TRUST
		 
		
12
	
	 	 	 	 
	 	 	 	 
	
ARTICLE 13
		
PRESUMPTIONS AND EFFECT OF CERTAIN
		 
		 

	
	 

		
PROCEEDINGS
		 
		
13
	
	 	 	 	 
	
ARTICLE 14
		
REMEDIES OF INDEMNITEE
		 
		
14
	
	 	 	 	 
	
ARTICLE 15
		
SECURITY
		 
		
16
	
	 	 	 	 
	
ARTICLE 16
		
GUARANTEE
		 
		
16
	
	 	 	 	 
	
ARTICLE 17
		
NON-EXCLUSIVITY; SURVIVAL OF RIGHTS; INSURANCE;
		 
		 

	
	 

		
SUBROGATION
		 
		
16
	
	 	 	 	 
	
ARTICLE 18
		
ENFORCEMENT AND BINDING EFFECT
		 
		
18
	

i

	
ARTICLE 19
		
MISCELLANEOUS
		 
		
19
	

 

 

 

 

 

 

 

ii

INDEMNIFICATION AGREEMENT

               This INDEMNIFICATION AGREEMENT
(this “Agreement”)
is made as of ____________, 2007, by and among Trian Acquisition I Corp.,
a Delaware corporation (the “Company”),
Trian Fund Management, L.P., a Delaware limited partnership (the “Trian
Management”) and
__________________ (“Indemnitee”). 

               WHEREAS, the Company desires to attract and retain the services of highly qualified individuals, such as Indemnitee, to serve the Company; 

               WHEREAS, in order to induce Indemnitee to provide or continue to provide services to the Company, the Company wishes to provide for the indemnification of, and advancement of expenses to, Indemnitee
to the fullest extent permitted by law; 

               WHEREAS, the Company and Indemnitee further recognize the substantial increase in corporate litigation in general, subjecting directors, officers, employees, agents and fiduciaries to expensive
litigation risks at the same time as the availability and scope of coverage of liability insurance provide increasing challenges for the Company.

               WHEREAS, the Company’s Certificate of Incorporation (as amended) (the “Certificate of Incorporation”) requires indemnification
of the officers and directors of the Company, and Indemnitee may also be entitled to indemnification pursuant to applicable provisions of the Delaware General Corporation Law (“DGCL”). The Certificate of Incorporation and the DGCL expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts providing for indemnification may be entered into
between the Company and members of the Company’s Board, executive officers and other key employees of the Company;

               WHEREAS, this Agreement is a supplement to and in furtherance of the Certificate of Incorporation and By-Laws of the Company and any resolutions adopted pursuant thereto, and shall not be deemed a
substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder (regardless of, among other things, any amendment to or revocation of governing documents or any change in the composition of the Company’s Board or any
Corporate Transaction relating to the Company); and 

               WHEREAS, Indemnitee will serve or continue to serve as a director, officer or key employee of the Company for so long as Indemnitee is duly elected or appointed or until Indemnitee tenders his
resignation or is otherwise terminated by the Company.

               NOW, THEREFORE, in consideration of the promises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree as follows:

ARTICLE 1 

DEFINITIONS

               As used in this Agreement:

               1.1.      “Affiliate” shall have the meaning set forth in Rule 405 under the
Securities Act of 1933, as amended (as in effect on the date hereof). 

               1.2.      “Business Combination” shall mean the acquisition, or acquisition of
control, through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination of one or more domestic or international operating businesses or assets meeting the conditions described in the
Company’s Registration Statement on Form S-1, as initially filed on the date hereof and as subsequently amended. 

               1.3.      “Beneficial Owner” and “Beneficial
Ownership” shall have the meaning set forth in Rule 13d-3 under the Exchange Act (as in effect on the date hereof); provided, however, that Beneficial Owner shall exclude any Person otherwise becoming a Beneficial Owner by reason of the stockholders of the Company approving a merger of the Company with another entity.

               1.4.      “Board” shall mean the Company’s Board of Directors. 

               1.5.      “Change in Control” shall mean, and shall be deemed to occur upon the
earliest to occur after the date of this Agreement of any of the following events:

          (a)      Acquisition
of Stock by Third Party. Any Person (other than
Trian Acquisition I, LLC, Nelson Peltz, Peter  W. May, Edward P. Garden or any
Affiliate thereof) is or becomes the Beneficial Owner, directly or indirectly,
of securities of the Company representing more than 30% of the combined voting
power of the Company’s then outstanding Voting
Securities, unless (i) the change in the relative Beneficial Ownership of the
Company’s securities by any Person results solely from a reduction in the
aggregate number of outstanding shares of securities entitled to vote generally
in the  election of directors, or (ii) such acquisition was approved in advance
by the Continuing Directors and such acquisition would not constitute a Change
in Control under part (c) of this definition; 

          (b)      Change
  in Board of Directors. Individuals who, as of the
  date hereof, constitute the Board, and any new  director whose election by the
  Board or nomination for election by the Company’s stockholders was approved
  by a vote of at least two-thirds of the directors then still in office who were
  directors on the date hereof or whose election for  nomination for election was
  previously so approved (collectively, the “Continuing
  Directors”), cease for any reason to constitute
  at least a majority of the members of the  Board;

2

               (c)      Corporate
Transactions. The effective date of a reorganization,
merger or consolidation of the Company (a
“Corporate Transaction”),
in each case, unless, following such Corporate Transaction: (i) all or substantially
all of the  individuals and entities who were the Beneficial Owners of Voting
Securities immediately prior to such Corporate Transaction beneficially own,
directly or indirectly, more than 51% of the combined voting power of the then
outstanding Voting  Securities of the Company resulting from such Corporate Transaction
(including, without limitation, a corporation that as a result of such transaction
owns the Company or all or substantially all of the Company’s assets either
directly or  through one or more Subsidiaries) in substantially the same proportions
as their ownership of Voting Securities immediately prior to such Corporate Transaction;
(ii) no Person (excluding any corporation resulting from such Corporate Transaction)
is  the Beneficial Owner, directly or indirectly, of 30% or more of the combined
voting power of the then outstanding Voting Securities of the surviving corporation
except to the extent that such ownership existed prior to the Corporate Transaction;
and  (iii) at least a majority of the Board of the corporation resulting from
such Corporate Transaction were Continuing Directors at the time of the execution
of the initial agreement, or of the action of the Board, providing for such Corporate
 Transaction;

               (d)      Liquidation.
   The approval by the stockholders of the Company of a complete liquidation
    of the Company or an agreement or series of agreements for the sale or disposition
   by the Company of all or substantially all of the Company’s assets, other
   than factoring the Company’s current receivables or escrows due (or,
   if such approval is not required, the decision by the Board to proceed with
   such a liquidation, sale, or disposition in one transaction or a series of
   related transactions); or

               (e)      Other
   Events. There occurs any other event of a nature
   that would be required to be reported in response  to Item 6(e) of Schedule
   14A of Regulation 14A (or a response to any similar item on any similar schedule
   or form) under the Exchange Act, whether or not the Company is then subject
   to such reporting requirement.

               1.6.      “Company” shall include, in addition to the resulting corporation or
other entity, any constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger that, if its separate existence had continued, would have had power and authority to indemnify its directors, officers,
employees or agents, so that if Indemnitee is or was a director, officer, employee or agent of such constituent corporation, or is or was serving at the request of such constituent corporation as a director, officer, employee or agent of another
corporation, partnership, joint venture, trust or other enterprise, Indemnitee shall stand in the same position under the provisions of this Agreement with respect to the resulting or surviving corporation or other entity as Indemnitee would have
with respect to such constituent corporation if its separate existence had continued. 

3

               1.7.      “Corporate Status” describes the status of a person who is or was a
director, officer, trustee, general partner, managing member, fiduciary, employee or agent of the Company or of any other Enterprise which such person is or was serving at the request of the Company.

               1.8.      “Delaware Court” shall mean the Court of Chancery of the State of
Delaware.

               1.9.      “Disinterested Director” shall mean a director of the Company who is
not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee.

               1.10.      “Enterprise” shall mean the Company and any other corporation,
constituent corporation (including any constituent of a constituent) absorbed in a consolidation or merger to which the Company (or any of its wholly owned subsidiaries) is a party, limited liability company, partnership, joint venture, trust,
employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer, trustee, general partner, managing member, fiduciary, employee or agent. 

               1.11.      “Exchange Act” shall mean the Securities Exchange Act of 1934, as
amended.

               1.12.      “Expenses” shall include all reasonable attorneys’ fees,
retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, and all other disbursements or expenses of the types
customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in, settling or negotiating for the settlement of, or otherwise participating in, a Proceeding.
Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or
its equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee. 

               1.13.      “Independent Counsel” shall mean a law firm, or a member of a law
firm, that is of outstanding reputation, experienced in matters of corporation law and neither is as of the date of selection of such firm, nor has been during the period of three years immediately preceding the date of selection of such firm,
retained to represent: (a) the Company or Indemnitee in any material matter (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements); or (b) any other party to
the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable standards of professional conduct then prevailing,
would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement. The Company agrees to pay the reasonable fees and expenses of the 

4

Independent Counsel referred to above and to fully indemnify such counsel against any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto. For purposes
of this definition, a “material matter” shall mean any matter for which billings exceeded or are expected to exceed $100,000. 

               1.14.      “Person” shall have the meaning as set forth in Sections 13(d) and
14(d) of the Exchange Act (as in effect on the date hereof); provided, however, that Person shall exclude: (a) the Company; (b) any
Subsidiaries of the Company; and (c) any employee benefit plan of the Company or a Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or of a Subsidiary of the Company or of a
corporation or other entity owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of stock of the Company.

               1.15.      “Proceeding” shall include any threatened, pending or completed
action, suit, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, including any and all appeals, whether brought in the right of the
Company or otherwise and whether of a civil (including intentional or unintentional tort claims), criminal, administrative or investigative nature, whether formal or informal, in which Indemnitee was, is, will or might be involved as a party or
otherwise by reason of the fact that Indemnitee is or was a director or officer of the Company, by reason of any action taken by or omission by Indemnitee, or of any action or omission on Indemnitee’s part while acting as a director or officer
of the Company, or by reason of the fact that Indemnitee is or was serving at the request of the Company as a director, officer, trustee, general partner, managing member, fiduciary, employee or agent of any other Enterprise, in each case whether or
not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement, or advancement of expenses can be provided under this Agreement or Section 145 of the DGCL; except one initiated by Indemnitee to
enforce Indemnitee’s rights under this Agreement or Section 145 of the DGCL.

               1.16.      “Subsidiary” with respect to any Person, shall mean any corporation
or other entity of which a majority of the voting power of the voting equity securities or equity interest is owned, directly or indirectly, by that Person.

               1.17.      “Voting Securities” shall mean any securities of the Company (or a
surviving entity as described in the definition of a “Change in Control”) that vote generally in the election of directors (or similar body). 

               1.18.      References to “fines” shall include any excise tax assessed on
Indemnitee with respect to any employee benefit plan; references to “other enterprise” shall include employee benefit plans; references to “serving at the request of the Company” shall include any service as a director, officer, employee, agent or fiduciary of the Company which
imposes duties on, or involves services by, such director, officer, employee, agent or fiduciary with respect to an employee benefit plan, its participants or 

5

beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the best interests of the participants and beneficiaries of an employee benefit plan, Indemnitee shall be deemed to have
acted in a manner “not opposed to the best interests of the Company” as referred to in this Agreement. 

               1.19.      The phrase “to the fullest extent not prohibited by (and not merely
to the extent affirmatively permitted by) applicable law” shall include, but not be limited to: (a) to the fullest extent authorized or permitted by the provision of the DGCL that
authorizes or contemplates additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of the DGCL, and (b) to the fullest extent authorized or permitted by any amendments to or replacements of the DGCL
adopted after the date of this Agreement that increase the extent to which a corporation may indemnify its officers and directors. 

ARTICLE 2

INDEMNITY IN THIRD-PARTY PROCEEDINGS

               Subject to Article 8, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this
Article 2 if Indemnitee is, was or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in
its favor. Subject to Article 8, to the fullest extent not prohibited by (and not merely to the extent affirmatively permitted by) applicable law, Indemnitee shall be indemnified against all
Expenses, judgments, fines and, subject to Section 10.3, amounts paid in settlement actually and reasonably incurred by Indemnitee or on
Indemnitee’s behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company and, in
the case of a criminal Proceeding, had no reasonable cause to believe that such conduct was unlawful.

ARTICLE 3

INDEMNITY IN PROCEEDINGS BY OR IN THE RIGHT OF THE COMPANY 

               Subject to Article 8, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this
Article 3 if Indemnitee is, was or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a judgment in its favor. Subject to
Article 8, to the fullest extent not prohibited by (and not merely to the extent affirmatively permitted by) applicable law, Indemnitee shall be indemnified, held harmless and exonerated
against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably
believed to be in or not opposed to the best interests of the Company. No indemnification for Expenses shall be made under this Article 3 in respect of any claim, issue or matter as to which
Indemnitee shall have been finally adjudged (and not subject to further appeal) by a court of 

6

competent jurisdiction to be liable to the Company, except to the extent that the Delaware Court or any court in which the Proceeding was brought shall determine upon application that, despite the adjudication of liability but in
view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification. 

ARTICLE 4

INDEMNIFICATION FOR EXPENSES OF A PARTY WHO IS WHOLLY OR 

PARTLY SUCCESSFUL 

               Notwithstanding any other provisions of this Agreement, to the extent that Indemnitee is a party to (or a participant in) and is successful, on the merits or otherwise, in any Proceeding or in defense
of any claim, issue or matter therein, in whole or in part, the Company shall indemnify, hold harmless and exonerate Indemnitee against all Expenses actually and reasonably incurred by Indemnitee in connection therewith. For the avoidance of doubt,
if Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify, hold harmless and exonerate
Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection with each resolved claim, issue or matter, whether or not Indemnitee was wholly or partly successful; provided, that Indemnitee shall only be entitled to Indemnification for Expenses with respect to unsuccessful claims under this Article 4 to the extent Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding,
had no reasonable cause to believe that such conduct was unlawful. For purposes of this Article 4 and without limitation, the termination of any claim, issue or matter in such a Proceeding
by dismissal, with or without prejudice, or by settlement, shall be deemed to be a successful result as to such claim, issue or matter.

ARTICLE 5

INDEMNIFICATION FOR EXPENSES OF A WITNESS

               Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is, by reason of Indemnitee’s Corporate Status, a witness in any Proceeding to which Indemnitee is not a
party, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee’s behalf in connection therewith. 

ARTICLE 6

ADDITIONAL INDEMNIFICATION, HOLD HARMLESS AND EXONERATION 

RIGHTS 

                 Notwithstanding any limitation in Articles 2, 3, or 4, but subject to Article 8, the Company shall indemnify, hold harmless and exonerate Indemnitee to the fullest

7

extent not prohibited by (and not merely to the extent affirmatively permitted by) law if Indemnitee is a party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to
procure a judgment in its favor) against all Expenses, judgments, fines and, subject to Section 10.3, penalties and amounts paid in settlement (including all interest, assessments and other
charges paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably incurred by Indemnitee in connection with the Proceeding. No indemnity shall be available
under this Article 6 on account of Indemnitee’s conduct that constitutes a breach of Indemnitee’s duty of loyalty to the Company or its stockholders or is an act or omission not in
good faith or that involves intentional misconduct or a knowing violation of the law.

ARTICLE 7

CONTRIBUTION IN THE EVENT OF JOINT LIABILITY

               7.1.      To the fullest extent not prohibited by (and not merely to the extent affirmatively permitted by) law, if the indemnification rights
provided for in this Agreement are unavailable to Indemnitee in whole or in part for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether for
judgments, liabilities, fines, penalties, amounts paid or to be paid in settlement and/or for Expenses, in connection with any Proceeding without requiring Indemnitee to contribute to such payment, and the Company and Trian Management hereby waive
and relinquish any right of contribution it may have at any time against Indemnitee.

               7.2.      The Company shall not enter into any settlement of any Proceeding in which the Company is jointly liable with Indemnitee (or would be if
joined in such Proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee.

               7.3.      The Company hereby agrees to fully indemnify, hold harmless and exonerate Indemnitee from any claims for contribution which may be brought
by officers, directors or employees of the Company (other than Indemnitee) who may be jointly liable with Indemnitee.

ARTICLE 8 

EXCLUSIONS

               8.1.      Notwithstanding any provision in this Agreement, the Company shall not be obligated under this Agreement to make any indemnity,
contribution or advancement of Expenses in connection with any claim made against Indemnitee: 

               (a)      for which payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except

8

with respect to any excess beyond the amount paid under any
insurance policy, contract, agreement, other indemnity provision or otherwise;

               (b)      for
  an accounting of profits made from the purchase and sale (or sale and purchase)
  by Indemnitee of securities of the Company within the  meaning of Section 16(b)
  of the Exchange Act or similar provisions of state statutory law or common
    law; or

               (c)      in
    connection with any Proceeding (or any part of any Proceeding) initiated
    or brought voluntarily by Indemnitee, including any Proceeding  (or any part
    of any Proceeding) initiated by Indemnitee against the Company or its directors,
    officers, employees or other indemnitees, other than a Proceeding initiated
    by Indemnitee to enforce its rights under this Agreement, unless (i) the
    Board  authorized the Proceeding (or any part of any Proceeding) or (ii)
    the Company provides the indemnification payment, in its sole discretion,
    pursuant to the powers vested in the Company under applicable law; or 

               (d)      for
    the payment of amounts required to be reimbursed to the Company pursuant
    to Section 304 of the Sarbanes-Oxley Act of 2002, as amended,  or any similar
    successor statute. 

               The exclusion in Section 8.1(c) shall not apply to counterclaims or affirmative defenses asserted by Indemnitee in an action brought against
Indemnitee.

ARTICLE 9

ADVANCES OF EXPENSES; SELECTION OF LAW FIRM

               9.1.      Subject to Article 8, the Company shall, unless prohibited by applicable law,
advance the Expenses incurred by Indemnitee (or reasonably expected by Indemnitee to be incurred by Indemnitee within three months) in connection with any Proceeding within ten business days after the receipt by the Company of a statement or
statements requesting such advances, together with a reasonably detailed written explanation of the basis therefor and an itemization of legal fees and disbursements in reasonable detail, from time to time, whether prior to or after final
disposition of any Proceeding. Advances shall be unsecured and interest free. Indemnitee shall qualify for advances, to the fullest extent permitted by applicable law, solely upon the execution and delivery to the Company of an undertaking providing
that Indemnitee undertakes to repay the advance to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company under the provisions of this Agreement. This Section
9.1 shall not apply to any claim made by Indemnitee for which an indemnification payment is excluded pursuant to Article 8.

               9.2.      If the Company shall be obligated under Section 9.1 hereof to pay the Expenses
of any Proceeding against Indemnitee, then the Company shall be entitled to assume the defense of such Proceeding upon the delivery to Indemnitee of written notice of its election to do so. If the Company elects to assume the defense of such

9

Proceeding, then unless the plaintiff or plaintiffs in such Proceeding include one or more Persons holding, together with his, her or its Affiliates, in the aggregate, a majority of the combined voting power of the Company’s
then outstanding Voting Securities, the Company shall assume such defense using a single law firm selected by the Company representing Indemnitee and other present and former directors or officers of the Company. The retention of such law firm by
the Company shall be subject to prior written approval by Indemnitee, which approval shall not be unreasonably withheld, delayed or conditioned. If the Company elects to assume the defense of such Proceeding and the plaintiff or plaintiffs in such
Proceeding include one or more Persons holding, together with his, her or its Affiliates, in the aggregate, a majority of the combined voting power of the Company’s then outstanding Voting Securities, then the Company shall assume such defense
using a single law firm selected by Indemnitee and any other present or former directors or officers of the Company who are parties to such Proceeding. After (x) in the case of retention of any such law firm selected by the Company, delivery of the
required notice to Indemnitee, approval of such law firm by Indemnitee and the retention of such law firm by the Company, or (y) in the case of retention of any such law firm selected by Indemnitee, the completion of such retention, the Company will
not be liable to Indemnitee under this Agreement for any Expenses of any other law firm incurred by Indemnitee after the date that such first law firm is retained by the Company with respect to the same Proceeding, provided, that in the case of retention of any such law firm selected by the Company (a) Indemnitee shall have the right to retain a separate law
firm in any such Proceeding at Indemnitee’s sole expense; and (b) if (i) the retention of a law firm by Indemnitee has been previously authorized by the Company, (ii) Indemnitee shall have reasonably concluded that there may be a conflict of
interest between either (1) the Company and Indemnitee or (2) Indemnitee and another present or former director or officer of the Company also represented by such law firm in the conduct of any such defense, or (iii) the Company shall not, in fact,
have retained a law firm to prosecute the defense of such Proceeding within 30 days, then the reasonable Expenses of a single law firm retained by Indemnitee shall be at the expense of the Company.

ARTICLE 10

PROCEDURE FOR NOTIFICATION; DEFENSE OF CLAIM; SETTLEMENT 

               10.1.      Indemnitee shall, as a condition precedent to Indemnitee’s right to be indemnified under this Agreement, give the Company (and Trian
Management if prior to a Business Combination) notice in writing promptly of any claim made against Indemnitee for which indemnification will or could be sought under this Agreement, provided, however, that a delay in giving such notice shall not deprive Indemnitee of any right to be indemnified under this Agreement unless, and then only to the extent that, such
delay is materially prejudicial to the defense of such claim. The omission to notify the Company (or Trian Management if prior to a Business Combination) will not relieve the Company from any liability for indemnification which it may have to
Indemnitee otherwise than under this Agreement. The Secretary of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification.

10

               10.2.      The Company will be entitled to participate in the Proceeding at its own expense. 

               10.3.      The Company shall have no obligation to indemnify Indemnitee under this Agreement for any amounts paid in settlement of any claim effected without the Company’s prior written consent, provided the Company has not breached its obligations hereunder. The Company shall not settle any
claim, including, without limitation, any claim in which it takes the position that Indemnitee is not entitled to indemnification in connection with such settlement, nor shall the Company settle any claim which would impose any fine or any
obligation on Indemnitee, without Indemnitee’s prior written consent. Neither the Company nor Indemnitee shall unreasonably withhold their consent to any proposed settlement.

ARTICLE 11

PROCEDURE UPON APPLICATION FOR INDEMNIFICATION

               11.1.      Upon written request by Indemnitee for indemnification pursuant to the first sentence of Section
10.1, a determination, if required by applicable law, with respect to Indemnitee’s entitlement thereto shall be made in the specific case: (a) if a Change in Control shall have occurred, by Independent Counsel in a
written opinion to the Board, a copy of which shall be delivered to Indemnitee; or (b) if a Change in Control shall not have occurred, (i) by a majority vote of the Disinterested Directors (provided there is a minimum of three Disinterested
Directors), even though less than a quorum of the Board, (ii) by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors (provided there is a minimum of three Disinterested Directors), even though less
than a quorum of the Board, or (iii) if there are less than three Disinterested Directors or, if such Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, and,
if it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten business days after such determination. Indemnitee shall cooperate with the person, persons or entity making such determination
with respect to Indemnitee’s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure
and which is reasonably available to Indemnitee and reasonably necessary to such determination, provided, that nothing contained in
this Agreement shall require Indemnitee to waive any privilege Indemnitee may have. Any costs or expenses (including reasonable attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or entity
making such determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom.

               11.2.      If the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 11.1 hereof, the Independent Counsel shall be selected as provided in this Section 11.2. If a Change in Control shall not have 

11

occurred, the Independent Counsel shall be selected by the Board, and the Company shall give written notice to Indemnitee advising Indemnitee of the identity of the Independent Counsel so selected. If a Change in Control shall
have occurred, the Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board, in which event the preceding sentence shall apply), and Indemnitee shall give written notice to the
Company advising it of the identity of the Independent Counsel so selected. In either event, Indemnitee or the Company, as the case may be, may, within ten business days after such written notice of selection shall have been given, deliver to the
Company or to Indemnitee, as the case may be, a written objection to such selection; provided, however, that such objection may be
asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Article 1 of this Agreement, and the
objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent
Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined that such objection is without merit. If, within 20 days after submission by Indemnitee of a written request for
indemnification pursuant to Section 10.1 hereof, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may seek arbitration for resolution of
any objection which shall have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the arbitrator or by such other person as the
arbitrator shall designate, and the person with respect to whom all objections are so resolved or the person so appointed shall act as Independent Counsel under Section 11.1 hereof. Such
arbitration referred to in the previous sentence shall be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. Upon the due commencement of any judicial proceeding pursuant to
Section 14.1 of this Agreement, Independent Counsel shall be discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional
conduct then prevailing). 

ARTICLE 12

ESTABLISHMENT OF TRUST

  In the event a Change in Control has occurred or is reasonably likely to occur, the Company shall, upon written request by Indemnitee, create a trust for the benefit of Indemnitee and from time to time upon written request of
Indemnitee shall fund such trust in an amount sufficient to satisfy any and all Expenses reasonably anticipated at the time of each such request to be incurred in connection with investigating, preparing for and defending any claim for
indemnification hereunder, and any and all judgments, fines, penalties and settlement amounts of any and all claims for indemnification from time to time actually paid or claimed, reasonably anticipated or proposed to be paid. The amount or amounts
to be deposited in the trust pursuant to the foregoing funding obligation shall be determined by the Independent Counsel. The terms of the trust shall provide that upon a Change in Control (i) the trust shall not be revoked or the principal thereof
invaded, without the written consent of Indemnitee, (ii) the trustee

12

shall advance, within five business days of a request by Indemnitee, any and all Expenses to Indemnitee (and Indemnitee hereby agrees to reimburse the trust under the circumstances under which Indemnitee would be required to
reimburse the Company under this Agreement), (iii) the trust shall continue to be funded by the Company in accordance with the funding obligation set forth above, (iv) the trustee shall promptly pay to Indemnitee all amounts for which Indemnitee
shall be entitled to indemnification pursuant to this Agreement or otherwise, and (v) all unexpended funds in such trust shall revert to the Company upon a final determination by the Independent Counsel or a court of competent jurisdiction, as the
case may be, that Indemnitee has been fully indemnified under the terms of this Agreement. The trustee shall be chosen by Indemnitee. Nothing in this Article 12 shall relieve the Company or
the Guarantor of any of its obligations under this Agreement. All income earned on the assets held in the trust shall be reported as income by the Company for federal, state, local and foreign tax purposes. The Company shall pay all costs of
establishing and maintaining the trust. 

ARTICLE 13

PRESUMPTIONS AND EFFECT OF CERTAIN PROCEEDINGS

               13.1.      In making a determination with respect to entitlement to indemnification hereunder, the Person making such determination shall presume
that Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 10.1 of this Agreement, and the
Company shall have the burden of proof to overcome that presumption in connection with the making by any Person of any determination contrary to that presumption. Neither the failure of the Company (including by its Board, its independent legal
counsel and its stockholders) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification or advancement of expenses is proper in the circumstances because Indemnitee has met the applicable
standard of conduct, nor an actual determination by the Company (including by its Board, its Independent Counsel and its stockholders) that Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a
presumption that Indemnitee has not met the applicable standard of conduct.

               13.2.      If the Person empowered or selected under Article 11 of this Agreement to
determine whether Indemnitee is entitled to indemnification shall not have made a determination within thirty days after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall be deemed to
have been made and Indemnitee shall be entitled to such indemnification, absent (a) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in
connection with the request for indemnification, or (b) a final judicial determination that any or all such indemnification is expressly prohibited under applicable law; provided,
however, that such 30-day period may be extended for a reasonable time, not to exceed an additional fifteen days, if the Person making the determination with respect to entitlement to
indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto.

13

               13.3.      The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement (with or without court
approval) or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in
this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best
interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that Indemnitee’s conduct was unlawful.

               13.4.      For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if, among other things,
Indemnitee’s action is based on the records or books of account of the Enterprise, including financial statements, or on information supplied to Indemnitee by the directors or officers of the Enterprise in the course of their duties, or on the
advice of legal counsel for the Enterprise, its Board, any committee of the Board or any director, or on information or records given or reports made to the Enterprise, its Board, any committee of the Board or any director, by an independent
certified public accountant or by an appraiser or other expert selected with reasonable care by the Enterprise, its Board, any committee of the Board or any director. The provisions of this Section 13.4 shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed or found to have met the applicable standard of conduct set forth in this Agreement.

               13.5.      The knowledge and/or actions, or failure to act, of any other director, officer, trustee, partner, managing member, fiduciary, agent or
employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to indemnification under this Agreement.

ARTICLE 14

REMEDIES OF INDEMNITEE

               14.1.      In the event that (a) a determination is made pursuant to Article 11 of this
Agreement that Indemnitee is not entitled to indemnification under this Agreement, (b) advancement of Expenses, to the fullest extent permitted by applicable law, is not timely made pursuant to Article 9 of this Agreement, (c) no determination of entitlement to indemnification shall have been made pursuant to Section 11.1 of this Agreement within thirty days after receipt by
the Company of the request for indemnification and of reasonable documentation and information which Indemnitee may be called upon to provide pursuant to Section 11.1, (d) payment of
indemnification is not made pursuant to Articles 4, 5, 6, or the last
sentence of Section 11.1 of this Agreement within ten business days after receipt by the Company of a written request therefor, (e) a contribution payment is not made in a timely manner
pursuant to Article 7 of this Agreement, or (f) payment of indemnification pursuant to Article 3 or 6 of this Agreement is not made within ten business days after a determination has been made that Indemnitee is entitled to indemnification, Indemnitee shall be entitled to an adjudication by a court of
Indemnitee’s entitlement to such indemnification, contribution or 

14

advancement of Expenses. Alternatively, Indemnitee, at his option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association.
Except as set forth herein, the provisions of Delaware law (without regard to its conflict of laws rules) shall apply to any such arbitration. The Company shall not oppose Indemnitee’s right to seek any such adjudication or award in
arbitration.

               14.2.      In the event that a determination shall have been made pursuant to Section 11.1 of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Article 14 shall be conducted in all
respects as a de novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Article
14, Indemnitee shall be presumed to be entitled to receive advances of Expenses under this Agreement and the Company shall have the burden of proving Indemnitee is not entitled to indemnification or advancement of
Expenses, as the case may be, and the Company may not refer to or introduce into evidence any determination pursuant to Section 11.1 of this Agreement adverse to Indemnitee for any purpose.
If Indemnitee commences a judicial proceeding or arbitration pursuant to this Article 14, Indemnitee shall not be required to reimburse the Company for any advances pursuant to
Article 9 until a final determination is made with respect to Indemnitee’s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).

               14.3.      If a determination shall have been made pursuant to Section 11.1 of this
Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Article 14,
absent (a) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (b) a prohibition of such
indemnification under applicable law.

               14.4.      The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Article 14 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all
the provisions of this Agreement.

               14.5.      The Company shall indemnify and hold harmless Indemnitee to the fullest extent permitted by law against all Expenses and, if requested by
Indemnitee, shall (within ten days after the Company’s receipt of such written request) pay to Indemnitee, to the fullest extent permitted by applicable law, such Expenses which are incurred by Indemnitee in connection with any judicial
proceeding or arbitration brought by Indemnitee (a) to enforce his rights under, or to recover damages for breach of, this Agreement or any other indemnification, advancement or contribution agreement or provision of the Certificate of
Incorporation, or the By-Laws now or hereafter in effect; or (b) for recovery or advances under any insurance policy maintained by any person for the benefit of Indemnitee, regardless of the outcome and whether Indemnitee ultimately 

15

is determined to be entitled to such indemnification, advancement, contribution or insurance recovery, as the case may be (unless such judicial proceeding or arbitration was not brought by Indemnitee in good faith).

               14.6.      Interest shall be paid by the Company to Indemnitee at the legal rate under Delaware law for amounts which the Company indemnifies, or is
obliged to indemnify, for the period commencing with the date on which Indemnitee requests indemnification, contribution, reimbursement or advancement of any Expenses and ending with the date on which such payment is made to Indemnitee by the
Company.

ARTICLE 15

SECURITY 

               Notwithstanding anything herein to the contrary, to the extent requested by Indemnitee and approved by the Board, the Company may at any time and from time to time provide security to Indemnitee for
the Company’s obligations hereunder through an irrevocable bank line of credit, funded trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the prior written consent of
Indemnitee.

ARTICLE 16 

GUARANTEE

               The obligations of the Company for indemnification, contribution, reimbursement or advancement of any Expenses set forth in this Agreement shall be guaranteed by Trian Management until such time as
the Company shall consummate a Business Combination at which time Trian Management shall be released from any and all obligations hereunder. 

ARTICLE 17

NON-EXCLUSIVITY; SURVIVAL OF RIGHTS; INSURANCE; SUBROGATION

               17.1.      The rights of Indemnitee as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any
time be entitled under applicable law, the Certificate of Incorporation, the Company’s By-Laws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. No amendment, alteration or repeal of this Agreement or of any
provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in Indemnitee’s Corporate Status prior to such amendment, alteration or repeal. To the extent
that a change in applicable law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the Certificate of Incorporation, the Company’s ByLaws or this
Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change. No right or remedy 

16

herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or
in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.

               17.2.      The DGCL, the Certificate of Incorporation and the Company’s By-Laws permit the Company to purchase and maintain insurance or
furnish similar protection or make other arrangements including, but not limited to, providing a trust fund, letter of credit, or surety bond (“Indemnification Arrangements”) on
behalf of Indemnitee against any liability asserted against him or incurred by or on behalf of him or in such capacity as a director, officer, employee or agent of the Company, or arising out of his status as such, whether or not the Company would
have the power to indemnify him against such liability under the provisions of this Agreement or under the DGCL, as it may then be in effect. The purchase, establishment, and maintenance of any such Indemnification Arrangement shall not in any way
limit or affect the rights and obligations of the Company or of Indemnitee under this Agreement except as expressly provided herein, and the execution and delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect
the rights and obligations of the Company or the other party or parties thereto under any such Indemnification Arrangement.

               17.3.      To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors, officers, trustees,
partners, managing members, fiduciaries, employees, or agents of the Company or of any other Enterprise which such person serves at the request of the Company, Indemnitee shall be covered by such policy or policies in accordance with its or their
terms to the maximum extent of the coverage available for any such director, officer, trustee, partner, managing member, fiduciary, employee or agent under such policy or policies. If, at the time the Company receives notice from any source of a
Proceeding as to which Indemnitee is a party or a participant (as a witness or otherwise), the Company has director and officer liability insurance in effect, the Company shall give prompt notice of the commencement of such Proceeding to the
insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such
Proceeding in accordance with the terms of such policies.

               17.4.      In the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of
recovery of Indemnitee, who shall execute all papers reasonably required and take all action reasonably necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such
rights.

               17.5.      The Company shall not be liable under this Agreement to make any payment of amounts otherwise indemnifiable (or for which advancement is
provided hereunder) hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise. 

17

               17.6.      The Company’s obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the
Company as a director, officer, trustee, partner, managing member, fiduciary, employee or agent of any other Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification payments or advancement of expenses from such
Enterprise. Notwithstanding any other provision of this Agreement to the contrary, (a) Indemnitee shall have no obligation to reduce, offset, allocate, pursue or apportion any indemnification advancement, contribution or insurance coverage among
multiple parties possessing such duties to Indemnitee prior to the Company’s satisfaction and performance of all its obligations under this Agreement, and (b) the Company shall perform fully its obligations under this Agreement without regard
to whether Indemnitee holds, may pursue or has pursued any indemnification, advancement, contribution or insurance coverage rights against any person or entity other than the Company.

ARTICLE 18

ENFORCEMENT AND BINDING EFFECT

               18.1.      The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in
order to induce Indemnitee to serve or continue to serve as a director, officer or key employee of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving or continuing to serve as a director, officer or
key employee of the Company.

               18.2.      This Agreement shall be effective as of the date set forth on the first page and may apply to acts or omissions of Indemnitee which
occurred prior to such date if Indemnitee was an officer, director, employee or other agent of the Company, or was serving at the request of the Company as a director, officer, employee or agent of another corporation, partnership, joint venture,
trust or other enterprise, at the time such act or omission occurred. 

               18.3.      The Company, Trian Management and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be
inadequate, impracticable and difficult to prove, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree that Indemnitee may enforce this Agreement by seeking, among other things, injunctive
relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be precluded from seeking or obtaining any other
relief to which he may be entitled. The Company, Trian Management and Indemnitee further agree that Indemnitee shall be entitled to such specific performance and injunctive relief, including temporary restraining orders, preliminary injunctions and
permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a waiver, a bond or undertaking may be 

18

required of Indemnitee by the Court, and the Company hereby waives any such requirement of such a bond or undertaking. 

ARTICLE 19 

MISCELLANEOUS

               19.1.      Successors and Assigns. This Agreement shall be binding upon the Company and its successors and assigns
and shall inure to the benefit of Indemnitee and Indemnitee’s heirs, executors and administrators. The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all,
substantially all or a substantial part, of the business and/or assets of the Company, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same
extent that the Company would be required to perform if no such succession had taken place. 

               19.2.      Severability. In the event that any provision of this Agreement is determined by a court to require the
Company to do or to fail to do an act which is in violation of applicable law, such provision (including any provision within a single Article, Section, paragraph or sentence) shall be limited or modified in its application to the minimum extent
necessary to avoid a violation of law, and, as so limited or modified, such provision and the balance of this Agreement shall be enforceable in accordance with their terms to the fullest extent permitted by law. 

               19.3.      Entire Agreement. Without limiting any of the rights of Indemnitee under the Certificate of
Incorporation or By-Laws of the Company as they may be amended from time to time, this Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and
understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof. 

               19.4.      Modification, Waiver and Termination. No supplement, modification, termination, cancellation or
amendment of this Agreement shall be binding unless executed in writing by the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any
waiver constitute a continuing waiver. 

               19.5.      Notices. All notices, requests, demands and other communications under this Agreement shall be in
writing and shall be deemed to have been duly given (a) if delivered by hand and receipted for by the party to whom said notice or other communication shall have been directed, or (b) mailed by certified or registered mail with postage prepaid, on
the third business day after the date on which it is so mailed: 

                  (i)      If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide in writing to the Company.

19

	 	
(ii)
		
If to the Company, to:
	
	 

	
	 	 

		
Trian Acquisition I Corp.
	
	 
	 	280 Park Avenue, 41st Floor
	 
		 	New York, New York 10017
	 	 

		
Attention: Chief Executive Officer
	

or to any other address as may have been furnished to Indemnitee in writing by the Company. 

	 
	(iii)
		
If to Trian Management:
	
	 	 	 
	 

		 
		
Trian Fund Management, L.P.
	
	 

		 
		
280 Park Avenue, 41st Floor
	
	 

		 
		
New York, New York 10017
	
	 

		 
		
Attention: Chief Legal Officer
	

or to any other address as may have been furnished to Indemnitee in writing by Trian Management. 

               19.6.      Applicable Law. This Agreement and the legal relations among the parties shall be governed by, and
construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. 

               19.7.      Identical Counterparts. This Agreement may be executed in one or more counterparts, each of which shall
for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to evidence the existence of
this Agreement. 

               19.8.      Headings. The headings of the paragraphs of this Agreement are inserted for convenience only and shall
not be deemed to constitute part of this Agreement or to affect the construction thereof. 

               19.9.      Period of Limitations. No legal action shall be brought and no cause of action shall be asserted by or
in the right of the Company against Indemnitee, Indemnitee’s spouse, heirs, executors or personal or legal representatives after the expiration of two years from the date of accrual of such cause of action, and any claim or cause of action of
the Company shall be extinguished and deemed released unless asserted by the timely filing of a legal action within such two-year period; provided, however, that if any shorter period of limitations is otherwise applicable to any such cause of action such shorter period shall govern. 

               19.10.      Additional Acts. If for the validation of any of the provisions in this Agreement any act, resolution,
approval or other procedure is required, the Company undertakes to cause such act, resolution, approval or other procedure to be affected or adopted in a manner that will enable the Company to fulfill its obligations under this Agreement.

20

                 IN WITNESS WHEREOF, the parties hereto have caused this Indemnity Agreement to be signed as of the day and year first above written.

	 	
      COMPANY:		 
	 	 	 
	 	
      TRIAN ACQUISITION I CORP.		 
	 	 	 

		 
	 	 	 	 
	 	By:	 
	 
	 	 	 Name:
		 
	 	 	 Title:
		 
	 	 	 

		 
	 	 	 
	 	
      GUARANTOR:		 
	 	 	 	 
	 	
      TRIAN FUND MANAGEMENT, L.P.		 
	 	 	 
	 	
      By: Trian Fund Management GP, LLC, its		 
	 	      general
	    partner		 
	 	 	 

		 
	 	 	 	 
	 	By:  	 
		 
	 	 	 Name:
		 
	 	 	 Title:
		 
	 	 	 

		 
	 	 	 	 
	 	
      INDEMNITEE:		 
	 	 	 

		 
	 	 	 	 
	 	By:	 
	 
	 	 	 Name:
		 
	 	 	 
	 	 	 
	 	
      Address:		 

 

21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}]]